S. Afelik and M. Rovira, Pancreas ?-cell regeneration: Facultative or dedicated progenitors?, Mol Cell Endocrinol, vol.445, pp.85-94, 2016.

F. Aguiree, A. Brown, N. Cho, and G. Dahlquist, ) IDF Diabetes Atlas. International Diabetes Federation, vol.03, pp.1-155, 2013.

K. G. Alberti and P. Z. Zimmet, Definition, diagnosis and classification of diabetes mellitus and its complications. Part1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation, Diabet, vol.15, pp.539-553, 1998.

A. E. Gregg, B. Blandino-rosano, M. Cras-méneur, C. Bernal-mizrachi, and E. , Natural history of beta-cell adaptation and failure in type 2 diabetes, Mol Asp Med, vol.1, pp.19-41, 2014.

, Classification and Diagnosis of Diabetes, Diabetes Care, vol.38, pp.8-16, 2015.

G. W. Arendash, M. F. Garcia, D. A. Costa, J. R. Cracchiolo, I. M. Wefes et al., Environmental enrichment improves cognition in aged Alzheimer's transgenic mice despite stable beta-amyloid deposition, vol.15, pp.1751-1754, 2004.

Z. Arvanitakis, R. S. Wilson, J. L. Bienias, D. Evans, and D. Bennett, Diabetes mellitus and risk of Alzheimer disease and decline in cognitive function, Arch Neurol, vol.61, pp.661-666, 2004.

M. E. Bamberger and G. E. Landreth, Inflammation, apoptosis and Alzheimer's Disease, vol.8, pp.276-283, 2002.

M. Barbagallo and L. J. Dominguez, Type 2 diabetes mellitus Alzheimer's disease, World J Diabetes, vol.5, pp.889-893, 2014.

E. M. Blalock, J. W. Geddes, K. C. Chen, N. M. Porter, W. R. Markesbery et al., Alzheimer's disease: Microarray correlation analyses reveal major transcriptional and tumor suppressor responses, Proc Natl Acad Sci, vol.101, pp.2173-2178, 2004.

A. M. Brant, T. J. Jess, G. Milligan, C. M. Brown, and G. W. Gould, Immunological analysis of glucose transporters expressed in different regions of the rat brain and central nervous system, Biochem Biophys Res Commun, vol.192, pp.1297-1302, 1993.

G. A. Bray, The Zucker-fatty rat: a review, Fed Proc, vol.36, pp.148-153, 1977.

E. Bruel-jungerman, S. Laroche, and C. Rampon, New neurons in the dentate gyrus are involved in the expression of enhanced long-term memory following environmental enrichment, Eur J Neurosci, vol.21, pp.513-521, 2005.
URL : https://hal.archives-ouvertes.fr/hal-00094594

E. Bruel-jungerman, A. Veyrac, F. Dufour, J. Horwood, S. Laroche et al., Inhibition of PI3K-Akt signaling blocks exercise-mediated enhancement of adult neurogenesis and synaptic plasticity in the dentate gyrus, PLoS One, vol.4, p.7901, 2009.
URL : https://hal.archives-ouvertes.fr/hal-02537350

A. Brunetti, E. Chiefari, and D. Foti, Recent advances in the molecular genetics of type 2 diabetes mellitus, World J Diabetes, vol.5, pp.128-140, 2014.

A. Caccamo, M. A. Maldonado, S. Majumder, D. X. Medina, W. Holbein et al., Naturally secreted amyloidb increases mammalian target of rapamycin (mTOR) activity via a PRAS40-mediated mechanism, J Biol Chem, vol.286, pp.8924-8932, 2011.

E. Candeias, A. I. Duarte, C. Carvalho, S. C. Correia, S. Cardoso et al., The impairment of insulin signaling in Alzheimer's disease, IUBMB Life, vol.64, pp.951-957, 2012.

A. Contestabile, Benefits of caloric restriction on brain aging and related pathological states: Understanding mechanisms to devise novel therapies, Cur Med Chem, vol.16, pp.350-361, 2009.

D. Cao, H. Lu, T. L. Lewis, and L. Li, Intake of sucrose-sweetened water induces insulin resistance and exacerbates memory deficits and amyloidosis in a transgenic mouse model of Alzheimer disease, J Biol Chem, vol.282, pp.36275-36282, 2007.

E. Carro, A. Nunez, S. Busiguina, and I. Torres-aleman, Circulating insulin-like growth factor I mediates effects of exercise on the brain, J Neurosci, vol.20, pp.2926-2933, 2000.

M. ?au?evi?, U. Farooq, S. Lovestone, and R. Killick, Beta-Amyloid precursor protein and tau protein levels are differently regulated in human cerebellum compared to brain regions vulnerable to Alzheimer's type neurodegeneration, Neurosci Lett, vol.485, pp.162-166, 2010.

L. Chang, W. Cui, Y. Yang, S. Xu, W. Zhou et al., Protection against ?-amyloid-induced synaptic and memory impairments via altering ?-amyloid assembly by bis(heptyl)-cognitin, Sci Rep, vol.5, pp.10256-10257, 2015.

Y. Chen, Z. Liang, J. Blanchard, C. L. Dai, S. Sun et al., A Nontransgenic Mouse Model (icv-STZ Mouse) of Alzheimer's Disease: Similarities to and Differences from the Transgenic Model (3xTg-AD Mouse), Mol Neurobiol, vol.47, pp.1-15, 2013.

J. P. Cleary, D. M. Walsh, J. J. Hofmeister, G. M. Shankar, D. J. Kuskowski-m-a,-selkoe et al., Natural oligomers of the amyloid-beta protein specifically disrupt cognitive function, Nat Neurosci, vol.8, pp.79-84, 2005.

A. R. Cole, A. Astell, C. Green, and C. Sutherland, Molecular connexions between dementia and diabetes, Neurosci Biobehav Rev, vol.31, pp.1046-1063, 2007.

D. G. Cook, J. B. Leverenz, P. J. Mcmillan, J. J. Kulstad, S. Ericksen et al., Reduced hippocampal insulin-degrading enzyme in late-onset Alzheimer's disease is associated with the apolipoprotein E-epsilon4 allele, Am J Pathol, vol.162, pp.313-319, 2003.

D. A. Costa, J. R. Cracchiolo, A. D. Bachstetter, T. F. Hughes, K. R. Bales et al., Enrichment improves cognition in AD mice by amyloid-related and unrelated mechanisms, Neurobiol Aging, vol.28, pp.831-844, 2007.

H. C. Dan, R. J. Antonia, and A. S. Baldwin, PI3K/Akt promotes feedforward mTORC2 activation through IKK?, Oncotarget, vol.7, pp.1-12, 2014.

S. Davis, P. Vanhoutte, C. Pages, J. Caboche, and S. Laroche, The MAPK/ERK cascade targets both Elk-1 and cAMP response element-binding protein to control long-term potentiation-dependent gene expression in the dentate gyrus in vivo, J Neurosci, vol.20, pp.4563-4572, 2000.
URL : https://hal.archives-ouvertes.fr/hal-00168752

D. Ferrari, G. Avila, M. E. Medina, M. A. Perez-palma, E. Bustos et al., Wnt/?-catenin signaling in Alzheimer's disease, CNS Neurol Disord Drug Targets, vol.13, pp.745-754, 2014.

D. Heijer, T. Vermeer, S. E. Van-dijk, E. J. Prins, N. D. Koudstaal et al., Type 2 diabetes and atrophy of medial temporal lobe structures on brain MRI, Diabetologia, vol.46, pp.1604-1610, 2003.

G. S. Desai, C. Zheng, T. Geetha, S. T. Mathews, B. D. White et al., The pancreas-brain axis: Insight into disrupted mechanisms associating type 2 diabetes and Alzheimer's disease, J Alzheimers Dis, vol.42, pp.347-356, 2014.

T. C. Dickson and J. C. Vickers, The morphological phenotype of beta-amyloid plaques and associated neuritic changes in Alzheimer's disease, Neuroscience, vol.105, pp.99-107, 2001.

B. Eftekharzadeh, M. Ramin, F. Khodagholi, S. Moradi, K. Tabrizian et al., Inhibition of PKA attenuates memory deficits induced by beta-amyloid (1-42), and decreases oxidative stress and NF-kappaB transcription factors, Behav Brain Res, vol.226, pp.301-308, 2012.

M. J. Eslamizade, Z. Madjd, H. Rasoolijazi, F. Saffarzadeh, V. Pirhajati et al., Impaired memory and evidence of histopathology in CA1 pyramidal neurons through injection of Abeta1-42 peptides into the frontal cortices of rat, Basic Clin Neurosci, vol.7, pp.31-42, 2016.

J. L. Garrido, J. A. Godoy, A. Alvarez, M. Bronfman, and N. C. Inestrosa, Protein kinase C inhibits amyloid beta peptide neurotoxicity by acting on members of the Wnt pathway, FASEB J, vol.16, pp.1982-1984, 2002.

R. Ghasemi, A. Zarifkar, K. Rastegar, N. Maghsoudi, and M. Moosavi, Repeated intra-hippocampal injection of betaamyloid 25-35 induces a reproducible impairment of learning and memory: Considering caspase-3 and MAPKs activity, Eur J Pharmacol, vol.726, pp.33-40, 2014.

D. Glick, S. Barth, and K. F. Macleod, Autophagy: cellular and molecular mechanisms, J Pathol, vol.221, pp.3-12, 2010.

C. Gong, F. Liu, I. Grundke-iqbal, and K. Iqbal, Impaired brain glucose metabolism leads to Alzheimer neurofibrillary degeneration through a decrease in tau O-GlcNAcylation, J Alzheimers Dis, vol.9, pp.1-12, 2006.

S. N. Goyal, N. M. Reddy, K. R. Patil, K. T. Nakhate, S. Ojha et al., Challenges and issues with streptozotocin-induced diabetes -A clinically relevant animal model to understand the diabetes pathogenesis and evaluate therapeutics, Chem Biol Interact, vol.244, pp.49-63, 2016.

E. L. Greer, P. R. Oskoui, M. R. Banko, J. M. Maniar, M. P. Gygi et al., The energy sensor AMP-activated protein kinase directly regulates the mammalian FOXO3 transcription factor, J Biol Chem, vol.282, pp.30107-30119, 2007.

R. J. Griffin, A. Moloney, M. Kelliher, J. A. Johnston, R. Ravid et al., Activation of Akt/PKB, increased phosphorylation of Akt substrates and loss and altered distribution of Akt and PTEN are features of Alzheimer's disease pathology, J Neurochem, vol.93, pp.105-117, 2005.

F. Guillot, S. Kemppainen, G. Lavasseur, P. O. Miettinen, S. Laroche et al., Brain-specific basal and novelty-induced alternations in PI3K-Akt and MAPK/ERK signaling in a middle-aged A?PP/PS1 mouse model of Alzheimer's disease, J Alzheimers Dis, vol.51, pp.1157-1173, 2016.

J. A. Hardy and G. A. Higgins, Alzheimer's disease: the amyloid cascade hypothesis, Science, vol.256, pp.184-185, 1992.

N. Harishankar, A. Vajreswari, and N. V. Giridharan, WNIN/GR-Ob an insulin-resistant obese rat model from inbred WNIN strain, Indian J Med Res, vol.134, pp.320-329, 2011.

P. He and Y. Shen, Interruption of ?-Catenin Signaling Reduces Neurogenesis in Alzheimer's Disease, J Neurosci, vol.29, pp.6545-6557, 2009.

K. Heininger, A unifying hypothesis of Alzheimer's disease. II. Pathophysiological processes, Hum Psychopharmacol Clin Exp, vol.14, pp.525-581, 1999.

W. D. Heiss, B. Szelies, J. Kessler, and K. Herholz, Abnormalities of energy metabolism in Alzheimer's disease studied with PET, Ann N Y Acad Sci, vol.640, pp.65-71, 1991.

F. L. Heppner, R. M. Ransohoff, and B. Becher, Immune attack: the role of inflammation in Alzheimer disease, Nat Rev Neurosci, vol.16, pp.358-372, 2015.

B. Herculano, M. Tamura, A. Ohba, M. Shimatani, N. Kutsuna et al., ) ?-alanyl-L-histidine rescues cognitive deficits caused by feeding a high fat diet in a transgenic mouse model of Alzheimer's disease, J Alzheimers Dis, vol.33, pp.983-997, 2013.

F. Hernández, J. Borrell, C. Guaza, J. Avila, and J. J. Lucas, Spatial learning deficit in transgenic mice that conditionally over-express GSK-3beta in the brain but do not form tau filaments, J Neurochem, vol.83, pp.1529-1533, 2002.

K. Herrup, The case for rejecting the amyloid cascade hypothesis, Nat Neurosci, vol.18, pp.794-799, 2015.

M. Hiltunen, V. Khandelwal, N. Yaluri, T. Tiilikainen, M. Tusa et al., Contribution of genetic and dietary insulin resistance to Alzheimer phenotype in APP/PS1 transgenic mice, J Cell Mol Med, vol.16, pp.1206-1222, 2012.

L. Ho, W. Qin, P. N. Pompl, Z. Xiang, J. Wang et al., Diet-induced insulin resistance promotes amyloidosis in a transgenic mouse model of Alzheimer's disease, Faseb J, vol.18, pp.902-904, 2004.

C. Holmes, D. Boche, D. Wilkinson, G. Yadegarfar, V. Hopkins et al., Long-term eff ects of A? 42 immunisation in Alzheimer' s disease : follow-up of a randomised, placebo-controlled phase I trial, vol.372, pp.11-14, 2008.

C. Hooper, V. Markevich, F. Plattner, R. Killick, E. Schofield et al., Glycogen synthase kinase-3 inhibition is integral to long-term potentiation, Eur J Neurosci, vol.25, pp.81-86, 2007.

S. Hoyer, Glucose metabolism and insulin receptor signal transduction in Alzheimer disease, Eur J Pharmacol, vol.490, pp.115-125, 2004.

Y. Hu, P. Xu, G. Pigino, S. T. Brady, J. Larson et al., Complex environment experience rescues impaired neurogenesis, enhances synaptic plasticity, and attenuates neuropathology in familial Alzheimer's disease-linked APPswe/PS1DeltaE9 mice, FASEB J, vol.24, pp.1667-1681, 2010.

A. Hye, F. Kerr, N. Archer, C. Foy, M. Poppe et al., Glycogen synthase kinase-3 is increased in white cells early in Alzheimer's disease, Neurosci Lett, vol.373, pp.1-4, 2005.

N. C. Inestrosa, D. Ferrari, G. V. Garrido, J. L. Alvarez, A. Olivares et al., Wnt signaling involvement in beta-amyloid-dependent neurodegeneration, Neurochem Int, vol.41, pp.341-344, 2002.

K. Iqbal and I. Grundke-iqbal, Metabolic/signal transduction hypothesis of Alzheimer?s disease and other tauopathies, Acta Neuropathol, vol.109, pp.25-31, 2005.

C. R. Jack, D. S. Knopman, W. J. Jagust, L. M. Shaw, P. S. Aisen et al., Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade, Lancet Neurol, vol.9, pp.119-128, 2010.

C. R. Jack, J. R. Barrio, and V. Kepe, Cerebral amyloid PET imaging in Alzheimer's disease, Acta Neuropathol, vol.126, pp.643-657, 2013.

J. Janson, T. Laedtke, J. E. Parisi, P. O'brien, R. C. Petersen et al., Increased risk of type 2 diabetes in Alzheimer disease, Diabetes, vol.53, pp.474-481, 2004.

M. Maesako, K. Uemura, M. Kubota, A. Kuzuya, K. Sasaki et al., Exercise is more effective than diet control in preventing high fat diet-induced ?-Amyloid deposition and Memory Deficit in Amyloid Precursor Protein Transgenic Mice, J Biol Chem, vol.287, pp.23024-23033, 2012.

D. H. Malin, M. K. Crothers, J. R. Lake, P. Goyarzu, R. E. Plotner et al., Hippocampal injections of Amyloid ?-peptide 1-40 impair subsequent one-trial/day reward learning, Neurobiol Learn Mem, vol.76, pp.125-137, 2001.

R. Mayeux and Y. Stern, epidemiology of Alzheimer disease, Alzheimer Dis Assoc Disord, vol.20, pp.58-62, 2006.

P. L. Mcclean and C. Hölscher, Lixisenatide, a drug developed to treat type 2 diabetes, shows neuroprotective effects in a mouse model of Alzheimer's disease, Neuropharmacology, vol.86, pp.241-258, 2014.

E. C. Mcnay, C. T. Ong, R. J. Mccrimmon, J. Cresswell, J. S. Bogan et al., Hippocampal memory processes are modulated by insulin and high-fat-induced insulin resistance, Neurobiol Learn Mem, vol.93, pp.546-553, 2010.

J. Mehla, B. C. Chauhan, and N. B. Chauhan, Experimental induction of type 2 diabetes in aging-accelerated mice triggered Alzheimer-like pathology and memory deficits, J Alzheimers Dis, vol.39, pp.145-162, 2014.

F. M. Menzies, K. Moreau, and D. C. Rubensztein, Protein misfolding disorders and macroautophagy, Cur Opin Cell Biol, vol.23, pp.190-197, 2011.

K. Mittal and D. P. Katare, Shared links between type 2 diabetes mellitus and Alzheimer's disease: A review, Diabetes Metab Syndr Clin Res Rev, vol.10, pp.1-6, 2016.

A. D. Mooradian, H. C. Chung, and G. N. Shah, GLUT-1 expression in the cerebra of patients with Alzheimer's disease, Neurobiol Aging, vol.18, pp.469-474, 1997.

F. Morroni, G. Sita, A. Tarozzi, R. Rimondini, and P. Hrelia, Early effects of A?1-42 oligomers injection in mice: Involvement of PI3K/Akt/GSK3 and MAPK/ERK1/2 pathways, Behav Brain Res, vol.314, pp.106-115, 2016.

L. Mosconi, S. Santi, . De, Y. Li, J. Li et al., Visual rating of medial temporal lobe metabolism in mild cognitive impairment and Alzheimer's disease using FDG-PET, Eur J Nucl Med Mol Imaging, vol.33, pp.210-221, 2006.

E. Mufson, M. Malek-ahmadi, S. Perez, and K. Chen, Braak staging, plaque pathology, and APOE status in elderly persons without cognitive impairment, Neurobiol Aging, vol.37, pp.147-153, 2016.

T. Nabeshima and A. Nitta, Memory impairment and neuronal dysfunction induced by beta-amyloid protein in rats, Tohoku J Exp Med, vol.174, pp.241-249, 1994.

E. Nassireslami, P. Nikbin, E. Amini, B. Payandemehr, F. Shaerzadeh et al., How sodium arsenite improve amyloid beta-induced memory deficit?, Physiol Behav, vol.163, pp.97-106, 2016.

C. Ngarmukos, E. L. Baur, and A. K. Kumagai, Co-localization of GLUT1 and GLUT4 in the blood-brain barrier of the rat ventromedial hypothalamus, Brain Res, vol.900, pp.1-8, 2001.

M. Obulesu and M. J. Lakshmi, Apoptosis in Alzheimer's Disease: An understanding of the physiology, pathology and therapeutic avenues, Neurochem Res, vol.39, pp.2301-2312, 2014.

H. Oh, J. Steffener, Q. R. Razlighi, C. Habeck, D. Liu et al., Abeta-related hyperactivation in frontoparietal control regions in cognitively normal elderly, Neurobiol Aging, vol.36, pp.3247-3254, 2015.

G. Pani, Neuroprotective effects of dietary restriction: Evidence and mechanisms, Semin Cell Dev Biol, vol.40, pp.106-114, 2015.

S. Patel and D. Santani, Role of NFkB in the pathogenesis of diabetes and its associated complications, Pharmacol Reports, vol.61, pp.595-603, 2009.

R. Peila, B. L. Rodriguez, and L. J. Launer, Type 2 Diabetes, APOE gene, and the risk for dementia and related pathologies, Diabetes, vol.51, pp.1256-1262, 2002.

D. Petrov, I. Pedrós, G. Artiach, F. X. Sureda, E. Barroso et al., High-fat diet-induced deregulation of hippocampal insulin signaling 98, 2015.

, and mitochondrial homeostasis deficiences contribute to Alzheimer disease pathology in rodents, Biochim Biophys Acta -Mol Basis Dis, vol.852, pp.1687-1699

C. J. Phiel, C. Wilson, V. Lee, and P. S. Klein, GSK-3? regulates production of Alzheimer's disease amyloid-beta peptides, Nature, vol.423, pp.435-439, 2003.

F. Pickford, E. Masliah, M. Britschgi, K. Lucin, R. Narasimhan et al., The autophagy-related protein beclin 1 shoes reduced expression in eary Alzheimer disease and regulates amyloid beta accumulation in mice, J Clin Invest, vol.118, pp.2190-2199, 2008.

W. Qin, W. Zhao, L. Ho, J. Wang, K. Walsh et al., Regulation of forkhead transcription factor FoxO3a contributes to calorie restriction-induced prevention of Alzheimer's disease-type amyloid neuropathology and spatial memory deterioration, Ann N Y Acad Sci, vol.1147, pp.335-347, 2008.

L. P. Reagan, Diabetes as a chronic metabolic stressor: Causes, consequences and clinical complications, Exp Neurol, vol.233, pp.68-78, 2012.

Y. D. Reijmer, M. Brundel, D. Bresser, J. Kappelle, L. J. Leemans et al., Microstructural white matter abnormalities and cognitive functioning in type 2 diabetes: A diffusion tensor imaging study, Diabetes Care, vol.36, pp.137-144, 2013.

T. Y. Reuter, Diet-induced models for obesity and type 2 diabetes, Drug Discov Today Dis Model, vol.4, pp.3-8, 2007.

E. J. Rivera, A. Goldin, N. Fulmer, R. Tavares, J. R. Wands et al., Insulin and insulin-like growth factor expression and function deteriorate with progression of Alzheimer's disease: link to brain reductions in acetylcholine, J Alzheimers Dis, vol.8, pp.247-268, 2005.

M. Sakono and T. Zako, Amyloid oligomers: Formation and toxicity of A? oligomers, FEBS J, vol.277, pp.1348-1358, 2010.

A. Salminen and K. Kaarniranta, Regulation of the aging process by autophagy, Trends Mol Med, vol.15, pp.217-224, 2009.

M. Schubert, D. Gautam, D. Surjo, K. Ueki, S. Baudler et al., Role for neuronal insulin resistance in neurodegenerative diseases, Proc Natl Acad Sci, vol.101, pp.3100-3105, 2004.

D. J. Selkoe, Soluble oligomers of the amyloid beta-protein impair synaptic plasticity and behavior, Behav Brain Res, vol.192, pp.106-113, 2008.

D. J. Selkoe and J. Hardy, The amyloid hypothesis of Alzheimer's disease at 25 years, EMBO Mol Med, vol.8, pp.595-608, 2016.

C. Shi, K. Viccaro, H. Lee, and K. Shah, Cdk5-Foxo3 axis: initially neuroprotective, eventually neurodegenerative in Alzheimer's disease models, J Cell Sci, vol.129, pp.1815-1830, 2016.

I. A. Simpson, K. R. Chundu, T. Davies-hill, W. G. Honer, and P. Davies, Decreased concentrations of GLUT1 and GLUT3 glucose transporters in the brains of patients with Alzheimer's disease, Ann Neurol, vol.35, pp.546-551, 1994.

E. Sipos, A. Kurunczi, Á. Kasza, J. Horváth, K. Felszeghy et al., Beta-Amyloid pathology in the entorhinal cortex of rats induces memory deficits: Implications for Alzheimer's disease, Neuroscience, vol.147, pp.28-36, 2007.

S. Skovsø, Modeling type 2 diabetes in rats using high fat diet and streptozotocin, J Diabetes Investig, vol.5, pp.349-358, 2014.

G. S. Smith, M. J. De-leon, A. E. George, A. Kluger, N. D. Volkow et al., Topography of cross-sectional and longitudinal glucose metabolic deficits in Alzheimer's disease. Pathophysiologic implications, Arch Neurol, vol.49, pp.1142-1150, 1992.

L. C. Souza, C. R. Jesse, M. S. Antunes, J. R. Ruff, D. De-oliveira-espinosa et al., Indoleamine-2,3-dioxygenase mediates neurobehavioral alterations induced by an intracerebroventricular injection of amyloid-beta1-42 peptide in mice, Brain Behav Immun, vol.56, pp.363-377, 2016.

P. Spilman, N. Podlutskaya, M. J. Hart, J. Debnath, O. Gorostiza et al., Inhibition of mTOR by rapamycin abolishes cognitive deficits and reduces amyloid-beta levels in a mouse model of Alzheimer's disease, PLoS One, vol.5, p.9979, 2010.

K. Srinivasan and P. Ramarao, Animal models in type 2 diabetes research: an overview, Indian J Med Res, vol.125, pp.451-472, 2007.

, Obesity: preventing and managing the global epidemic, World Health Organ Tech Rep Ser, vol.894, pp.1-253, 2000.

C. W. Yeh, S. Yeh, F. S. Shie, W. S. Lai, H. K. Liu et al., Impaired cognition and cerebral glucose regulation are associated with astrocyte activation in the parenchyma of metabolically stressed APPswe/PS1dE9 mice, Neurobiol Aging, vol.36, pp.2984-2994, 2015.

Z. Zhang, H. Hartmann, V. M. Do, D. Abramowski, C. Sturchler-pierrat et al., Destabilization of beta-catenin by mutations in presenilin-1 potentiates neuronal apoptosis, Nature, vol.395, pp.698-702, 1998.

W. Zhao, D. Felice, F. G. Fernandez, S. Chen, H. Lambert et al., Amyloid beta oligomers induce impairment of neuronal insulin receptors, FASEB J, vol.22, pp.246-260, 2008.

Z. C. Zhao, F. Li, and K. Maiese, Oxidative stress in the brain: Novel cellular targets that govern survival during neurodegenerative disease, Prog Neurobiol, vol.75, pp.207-246, 2005.

M. M. Adams, L. Shi, M. C. Linville, M. E. Forbes, A. B. Long et al., Caloric restriction and age affect synaptic proteins in hippocampal CA3 and spatial learning ability, Exp Neurol, vol.211, pp.141-149, 2008.

P. A. Adlard, V. M. Perreau, V. Pop, and C. W. Cotman, Voluntary exercise decreases amyloid load in a transgenic model of Alzheimer's Disease, vol.25, pp.4217-4221, 2005.

F. Aguiree, A. Brown, N. Cho, and G. Dahlquist, ) IDF Diabetes Atlas. International Diabetes Federation, vol.03, pp.1-155, 2013.

H. J. Aizenstein, R. D. Nebes, J. A. Saxton, J. C. Price, C. A. Mathis et al., Frequent amyloid deposition without significant cognitive impairment among the elderly, Arch Neurol, vol.65, pp.1509-1517, 2008.

A. Akomolafe, A. Beiser, J. B. Meigs, R. Au, and R. C. Green, Diabetes mellitus and risk of developing Alzheimer disease, Arch Neurol, vol.63, pp.1551-1555, 2006.

A. Kupai, K. Veszelka, M. Sz?cs, G. Attieh, Z. Murlasits et al., Experimental diabetes mellitus in different animal models, J Diabetes Res, vol.2016, pp.1-12, 2016.

K. G. Alberti and P. Z. Zimmet, Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation, Diabet Med, vol.15, pp.539-553, 1998.

A. E. Gregg, B. Blandino-rosano, M. Cras-méneur, C. Bernal-mizrachi, and E. , Natural history of beta-cell adaptation and failure in type 2 diabetes, Mol Asp Med, vol.1, pp.19-41, 2014.

A. M. Stranahan, D. Khalil, and E. G. , Running induces widespread structural alterations in the hippocampus and entorhinal cortex, Hippocampus, vol.17, pp.801-812, 2007.

P. Alexopoulos, J. Roesler, N. Thierjung, L. Werle, D. Buck et al., Mapping CSF biomarker profiles onto NIA-AA guidelines for Alzheimer's disease, Eur Arch Psychiatry Clin Neurosci, vol.266, pp.587-597, 2016.

T. Allinson, E. T. Parkin, A. J. Turner, and N. M. Hooper, ADAMs family members as amyloid precursor protein alphasecretases, J Neurosci Res, vol.74, pp.342-352, 2003.

O. P. Almeida, G. K. Hulse, D. Lawrence, and L. Flicker, Smoking as a risk factor for Alzheimer's disease: contrasting evidence from a systematic review of case-control and cohort studies, Addiction, vol.97, pp.15-28, 2002.

O. Almkvist, H. Basun, S. L. Wagner, B. A. Rowe, L. O. Wahlund et al., Cerebrospinal fluid levels of alphasecretase-cleaved soluble amyloid precursor protein mirror cognition in a Swedish family with Alzheimer disease and a gene mutation, Arch Neurol, vol.54, pp.641-644, 1997.

, Alzheimer's Disease International (ADI) (2010) World Alzheimer Report 2010: The Global Economic Impact of Dementia, pp.1-52

, Classification and Diagnosis of Diabetes, Diabetes Care, vol.38, pp.8-16, 2015.

K. Andersen, L. J. Launer, M. E. Dewey, L. Letenneur, A. Ott et al., Gender differences in the incidence of AD and vascular dementia: The EURODEM Studies. EURODEM Incidence Research Group, vol.53, pp.1992-1997, 1999.

J. J. Anderson, G. Holtz, P. P. Baskin, R. Wang, L. Mazzarelli et al., Reduced cerebrospinal fluid levels of alpha-secretase-cleaved amyloid precursor protein in aged rats: correlation with spatial memory deficits, Neuroscience, vol.93, pp.1409-1420, 1999.

R. M. Anderson and R. Weindruch, The caloric restriction paradigm: Implications for healthy human aging, Am J Hum Biol, vol.24, pp.101-106, 2012.

A. Aplin, J. S. Jacobsen, B. H. Anderton, and J. M. Gallo, Effect of increased glycogen synthase kinase-3 activity upon the maturation of the amyloid precursor protein in transfected cells, Neuroreport, vol.8, pp.639-643, 1997.

E. M. Arenaza-urquijo, M. Wirth, and G. Chételat, Cognitive reserve and lifestyle: moving towards preclinical Alzheimer's disease, Front Aging Neurosci, vol.7, p.134, 2015.
URL : https://hal.archives-ouvertes.fr/inserm-01668609

G. W. Arendash, M. N. Gordon, D. M. Diamond, . Austin-l-a, J. M. Hatcher et al., Behavioral assessment of Alzheimer's transgenic mice following long-term Abeta vaccination: task specificity and correlations between Abeta deposition and spatial memory, DNA Cell Biol, vol.20, pp.737-744, 2001.

P. Arriagada, K. Marzloff, and B. T. Hyman, Distribution of Alzheimer-type pathologic changes in nondemented elderly individuals matches the pattern in Alzheimer's disease, Neurology, vol.42, pp.1681-1688, 1992.

Z. Arvanitakis, R. S. Wilson, J. L. Bienias, . Evans-d-a, and D. Bennett, Diabetes mellitus and risk of Alzheimer disease and decline in cognitive function, Arch Neurol, vol.61, pp.661-666, 2004.

S. O. Bachurin, E. V. Bovina, and A. A. Ustyugov, Drugs in clinical trials for Alzheimer's Disease: The major trends, Med Res Rev, vol.0, pp.1-41, 2017.

J. M. Backer, The regulation and function of Class III PI3Ks: novel roles for Vps34, Biochem J, vol.410, pp.1-17, 2008.

W. A. Banks, J. B. Owen, and M. A. Erickson, Insulin in the Brain : There and back again, Pharmacol Ther, vol.136, pp.82-93, 2014.

J. Bao, F. Atkinson, P. Petocz, W. C. Willett, and J. C. Brand-miller, Prediction of postprandial glycemia and insulinemia in lean, young, healthy adults: Glycemic load compared with carbohydrate content alone, Am J Clin Nutr, vol.93, pp.984-996, 2011.

M. Barbagallo and L. J. Domingue, Type 2 diabetes mellitus and Alzheimer's disease, World J Diabetes, vol.5, pp.889-893, 2014.

C. A. Barnes, Memory deficits associated with senescence: a neurophysiological and behavioral study in the rat, J Comp Physiol Psychol, vol.93, pp.74-104, 1979.

D. E. Barnes and K. Yaffe, The projected effect of risk factor reduction on Alzheimer's disease prevalence, Lancet Neurol, vol.10, pp.819-828, 2011.

R. J. Bateman, C. Xiong, T. L. Benzinger, A. M. Fagan, A. Goate et al., Clinical and biomarker changes in dominantly inherited Alzheimer's disease, N Engl J Med, vol.367, pp.795-804, 2012.

L. Baum and H. K. Ng, A new kind of Alzheimer's disease plaque, Adv Anat Pathol, vol.5, pp.170-174, 1998.

F. Baumkötter, N. Schmidt, C. Vargas, S. Schilling, R. Weber et al., Amyloid precursor protein dimerization and synaptogenic function depend on copper binding to the growth factor-like domain, J Neurosci, vol.34, pp.11159-11172, 2014.

A. J. Bayer, R. Bullock, R. W. Jones, D. Wilkinson, K. R. Paterson et al., Evaluation of the safety and immunogenicity of synthetic A 42 (AN1792) in patients with AD, Neurology, vol.64, pp.94-101, 2005.

T. G. Beach, R. Walker, and E. G. Mcgeer, Patterns of gliosis in alzheimer's disease and aging cerebrum, Glia, vol.2, pp.420-436, 1989.

J. Beauquis, P. Roig, D. Nicola, A. F. Saravia, and F. , Short-term environmental enrichment enhances adult neurogenesis, vascular network and dendritic complexity in the hippocampus of type 1 diabetic mice, PLoS One, vol.5, p.13993, 2010.

N. D. Belyaev, N. N. Nalivaeva, N. Z. Makova, and A. J. Turner, Neprilysin gene expression requires binding of the amyloid precursor protein intracellular domain to its promoter: implications for Alzheimer disease, EMBO Rep, vol.10, pp.94-100, 2009.

E. E. Benarroch, Insulin-like growth factors in the brain and their potential clinical implications, Neurology, vol.79, pp.2148-2153, 2012.

D. A. Bennett, J. A. Schneider, Z. Arvanitakis, J. F. Kelly, N. T. Aggarwal et al., Neuropathology of older persons without cognitive impairment from two community-based studies, Neurology, vol.66, pp.1837-1844, 2006.

Y. Benomar, N. Naour, A. Aubourg, V. Bailleux, A. Gertler et al., Insulin and leptin induce Glut4 plasma membrane translocation and glucose uptake in a human neuronal cell line by a phosphatidylinositol 3-kinase-dependent mechanism, Endocrinology, vol.147, pp.2550-2556, 2006.
URL : https://hal.archives-ouvertes.fr/hal-02754383

E. Bergamini, G. Cavallini, A. Donati, and Z. Gori, The role of autophagy in aging: Its essential part in the anti-aging mechanism of caloric restriction, Ann N Y Acad Sci, vol.1114, pp.69-78, 2007.

H. G. Bernstein, S. Ansorge, P. Riederer, M. Reiser, L. Frölich et al., Insulin-degrading enzyme in the Alzheimer's disease brain: prominent localization in neurons and senile plaques, Neurosci Lett, vol.263, pp.161-164, 1999.

V. Berti, C. Polito, G. Lombardi, C. Ferrari, S. Sorbi et al., Rethinking on the concept of biomarkers in preclinical Alzheimer's disease, Neurol Sci, vol.37, pp.663-672, 2016.

C. Betterle, F. Zanette, B. Pedini, F. Presotto, L. B. Rapp et al., Clinical and subclinical organspecific autoimmune manifestations in type 1 (insulin-dependent) diabetic patients and their first-degree relatives, Diabetologia, vol.26, pp.431-436, 1984.

H. Bickel and A. Kurz, Education, occupation, and dementia: The bavarian school sisters study, Dement Geriatr Cogn Disord, vol.27, pp.548-556, 2009.

S. B. Biddinger and C. R. Kahn, From mice to men: insights into the insulin resistance syndromes, J Biol Chem, vol.68, pp.123-158, 2006.

S. V. Biedermann, J. Fuss, J. Steinle, M. K. Auer, C. Dormann et al., The hippocampus and exercise: histological correlates of MR-detected volume changes, Brain Struct Funct, vol.221, pp.1353-1363, 2016.

G. J. Biessels, D. Leeuw, F. Lindeboom, J. Barkhof, F. Scheltens et al., Increased cortical atrophy in patients with Alzheimer's disease and type 2 diabetes mellitus, J Neurol Neurosurg Psychiatry, vol.77, pp.304-307, 2006.

G. J. Biessels and Y. D. Reijmer, Brain changes underlying cognitive dysfunction in diabetes: What can we learn from MRI?, Diabetes, vol.63, pp.2244-2252, 2014.

G. J. Biessels, L. P. Van-der-heide, A. Kamal, R. Bleys, and W. H. Gispen, Ageing and diabetes: Implications for brain function, Eur J Pharmacol, vol.441, pp.1-14, 2002.

L. M. Billings, S. Oddo, K. N. Green, J. L. Mcgaugh, and F. M. Laferla, Intraneuronal A? causes the onset of early Alzheimer's disease-related cognitive deficits in transgenic mice, Neuron, vol.45, pp.675-688, 2005.

T. Bittner, M. Fuhrmann, S. Burgold, S. M. Ochs, N. Hoffmann et al., Multiple events lead to dendritic spine loss in triple transgenic Alzheimer's disease mice, PLoS One, vol.5, pp.1-9, 2010.

E. Blazquez, E. Velozquez, V. Hurtado-carneiro, and J. M. Ruiz-albusac, Insulin in the brain: Its pathophysiological implications for states related with central insulin resistance, type 2 diabetes and alzheimer's disease, Front Endocrinol (Lausanne), vol.5, pp.1-21, 2014.

K. Blennow, H. Hampel, M. Weiner, and H. Zetterberg, Cerebrospinal fluid and plasma biomarkers in Alzheimer disease, Nat Rev Neurol, vol.6, pp.131-144, 2010.

H. C. Blodgett and K. Mccutchan, Place versus response learning in the simple T-maze, J Exp Psychol, vol.37, pp.412-422, 1947.

K. Boekhoorn, Improved long-term potentiation and memory in young Tau-P301L transgenic mice before onset of hyperphosphorylation and tauopathy, J Neurosci, vol.26, pp.3514-3523, 2006.

C. Boitard, A. Cavaroc, J. Sauvant, A. A. Castanon, N. Laye et al., Impairment of hippocampaldependent memory induced by juvenile high-fat diet intake is associated with enhanced hippocampal inflammation in rats, Brain Behav Immun, vol.40, pp.9-17, 2014.
URL : https://hal.archives-ouvertes.fr/hal-02638223

F. Boller, K. Bick, and C. Duyckaerts, They have shaped Alzheimer disease: The protagonists, well known and less well known, Cortex, vol.43, pp.565-569, 2007.

S. Y. Bookheimer, M. H. Strojwas, M. S. Cohen, A. M. Saunders, M. A. Pericak-vance et al., Patterns of brain activation in people at risk for Alzheimer's Disease, N Engl J Med, vol.343, pp.450-456, 2000.

D. R. Borchelt, T. Ratovitski, J. Van-lare, M. K. Lee, V. Gonzales et al., Accelerated amyloid deposition in the brains of transgenic mice coexpressing mutant presenilin 1 and amyloid precursor proteins, Neuron, vol.19, pp.939-945, 1997.

H. Braak, I. Alafuzoff, T. Arzberger, H. Kretzschmar, and D. Tredici, Staging of Alzheimer disease-associated neurofibrillary pathology using paraffin sections and immunocytochemistry, Acta Neuropathol, vol.112, pp.389-404, 2006.

H. Braak and E. Braak, Neuropathological stageing of Alzheimer-related changes, Acta Neuropathol, vol.82, pp.239-259, 1991.

F. H. Brembeck, M. Rosário, and W. Birchmeier, Balancing cell adhesion and Wnt signaling, the key role of beta-catenin, Curr Opin Genet Dev, vol.16, pp.51-59, 2006.

J. Brion, Immunological demonstration of tau protein in neurofibrillary tangles of Alzheimer's disease, J Alzheimers Dis, vol.9, pp.177-185, 1985.

J. Brito-moreira, P. -. Lima, A. C. Bomfim, T. R. Oliveira, F. B. Sepúlveda et al., A? oligomers induce glutamate release from hippocampal neurons, Curr Alzheimer Res, vol.8, pp.552-562, 2011.

A. Brunet, A. Bonni, M. J. Zigmond, M. Z. Lin, P. Juo et al., Akt promotes cell survival by phosphorylating and inhibiting a Forkhead Transcription Factor, Cell, vol.96, pp.857-868, 1999.

A. Brunetti, E. Chiefari, and D. Foti, Recent advances in the molecular genetics of type 2 diabetes mellitus, World J Diabetes, vol.5, pp.128-140, 2014.

L. B. Buckman, A. H. Hasty, D. K. Flaherty, C. T. Buckman, M. M. Thompson et al., Obesity induced by a high-fat diet is associated with increased immune cell entry into the central nervous system, Brain Behav Immun, vol.35, pp.33-42, 2014.

R. L. Buckner, A. Z. Snyder, B. J. Shannon, G. Larossa, R. Sachs et al., Molecular, structural, and functional characterization of Alzheimer's Disease: Evidence for a relationship between default activity, amyloid, and memory, J Neurosci, vol.25, pp.7709-7717, 2005.

R. Buettner, J. Schölmerich, and L. C. Bollheimer, High-fat diets: modeling the metabolic disorders of human obesity in rodents, Obesity (Silver Spring), vol.15, pp.798-808, 2007.

A. I. Bush, K. Beyreuther, and C. L. Masters, The beta A4 amyloid protein precursor in human circulation, Ann N Y Acad Sci, vol.695, pp.175-182, 1993.

A. E. Butler, J. Janson, S. Bonner-weir, R. Ritzel, R. A. Rizza et al., Beta-cell deficit and increased beta-cell apoptosis in humans with type 2 diabetes, Diabetes, vol.52, pp.102-110, 2003.

O. Cabrera, D. M. Berman, N. S. Kenyon, C. Ricordi, P. Berggren et al., The unique cytoarchitecture of human pancreatic islets has implications for islet cell function, Proc Natl Acad Sci U S A, vol.103, pp.2334-2339, 2006.

A. Caccamo, S. Majumder, A. Richardson, R. Strong, and S. Oddo, Molecular Interplay between mammalian target of rapamycin (mTOR), amyloid-? , and Tau: effects on cognitive implairments, J Biol Chem, vol.285, pp.13107-13120, 2010.

A. Caccamo, M. A. Maldonado, S. Majumder, D. X. Medina, W. Holbein et al., Naturally secreted amyloid? increases mammalian target of rapamycin (mTOR) activity via a PRAS40-mediated mechanism, J Biol Chem, vol.286, pp.8924-8932, 2011.

D. Cai, Neuroinflammation in overnutrition-induced diseases, Vitamins and Hormones, vol.91, pp.195-218, 2013.

D. Cai, M. Yuan, D. F. Frantz, P. A. Melendez, L. Hansen et al., Local and systemic insulin resistance resulting from hepatic activation of IKK-beta and NF-kappaB, Nat Med, vol.11, pp.183-190, 2005.

I. Caillé, B. Allinquant, E. Dupont, C. Bouillot, A. Langer et al., Soluble form of amyloid precursor protein regulates proliferation of progenitors in the adult subventricular zone, Development, vol.131, pp.2173-2181, 2004.

C. K. Callaghan and Á. M. Kelly, Differential BDNF signaling in dentate gyrus and perirhinal cortex during consolidation of recognition memory in the rat, Hippocampus, vol.22, pp.2127-2135, 2012.

F. Calon, G. P. Lim, F. Yang, T. Morihara, B. Teter et al., Docosahexaenoic acid protects from dendritic pathology in an Alzheimer's disease mouse model, Neuron, vol.43, pp.633-645, 2004.

E. Candeias, A. I. Duarte, C. Carvalho, S. C. Correia, S. Cardoso et al., The impairment of insulin signaling in Alzheimer's disease, IUBMB Life, vol.64, pp.951-957, 2012.

Q. Cao, K. Jiang, M. Zhang, Y. Liu, S. Xiao et al., Brain glucose metabolism and neuropsychological test in patients with mild cognitive impairment, Chin Med J (Engl), vol.116, pp.1235-1238, 2003.

G. L. Caporaso, K. Takei, S. E. Gandy, M. Matteoli, O. Mundigl et al., Morphologic and biochemical analysis of the intracellular trafficking of the Alzheimer ?/A4 amyloid precursor protein, J Neurosci, vol.14, pp.3122-3138, 1994.

A. N. Carey, S. M. Gomes, and B. Shukitt-hale, Blueberry supplementation improves memory in middle-aged mice fed a high-fat diet, J Agric Food Chem, vol.62, pp.3972-3978, 2014.

E. Carro, A. Nuñez, S. Busiguina, and I. Torres-aleman, Circulating insulin-like growth factor I mediates effects of exercise on the brain, J Neurosci, vol.20, pp.2926-2933, 2000.

A. Carter, J. Hendrikse, N. Lee, M. Yücel, A. Verdejo-garcia et al., The Neurobiology of "Food Addiction" and its implications for obesity treatment and policy, Annu Rev Nutr, vol.36, pp.105-128, 2016.

B. J. Catlow, A. R. Rowe, C. R. Clearwater, M. Mamcarz, G. W. Arendash et al., Effects of environmental enrichment and physical activity on neurogenesis in transgenic PS1 / APP mice, Brain Res, vol.1256, pp.173-179, 2008.

M. ?au?evi?, U. Farooq, S. Lovestone, and R. Killick, ) ?-Amyloid precursor protein and tau protein levels are differently regulated in human cerebellum compared to brain regions vulnerable to Alzheimer's type neurodegeneration, Neurosci Lett, vol.485, pp.162-166, 2010.

E. Cavallini, A. Pagnin, and T. Vecchi, Aging and everyday memory: The beneficial effect of memory training, Arch Gerontol Geriatr, vol.37, pp.241-257, 2003.

K. A. Celone, V. D. Calhoun, B. C. Dickerson, A. Atri, E. F. Chua et al., Alterations in memory networks in mild cognitive impairment and Alzheimer's Disease: An independent component analysis, J Neurosci, vol.26, pp.10222-10231, 2006.

A. Chaalal, R. Poirier, D. Blum, B. Gillet, L. Blanc et al., PTU-induced hypothyroidism in rats leads to several early neuropathological signs of Alzheimer's disease in the hippocampus and spatial memory impairments, Hippocampus, vol.24, pp.1381-1393, 2014.

E. H. Chang, M. J. Savage, D. G. Flood, J. M. Thomas, R. B. Levy et al., AMPA receptor downscaling at the onset of Alzheimer's disease pathology in double knockin mice, Proc Natl Acad Sci U S A, vol.103, pp.3410-3415, 2006.

K. Chang, H. Kim, T. Ha, J. Ha, K. Y. Shin et al., Phosphorylation of amyloid precursor protein (APP) at Thr668 regulates the nuclear translocation of the APP intracellular domain and induces neurodegeneration, Mol Cell Biol, vol.26, pp.4327-4338, 2006.

L. Chang and S. Chiang, Insulin signaling and the regulation of glucose transport, Mol Med, vol.12, p.1, 2005.

D. T. Chao and S. J. Korsmeyer, BCL-2 FAMILY: Regulators of cell death, Annu Rev Immunol, pp.395-419, 1998.

P. F. Chapman, G. L. White, M. W. Jones, D. Cooper-blacketer, V. J. Marshall et al., Impaired synaptic plasticity and learning in aged amyloid precursor protein transgenic mice, Nat Neurosci, vol.2, pp.271-276, 1999.

N. Chapuis, S. Park, L. Leotoing, J. Tamburini, F. Verdier et al., I?B kinase overcomes PI3K/Akt and ERK/MAPK to control FOXO3a activity in acute myeloid leukemia, Blood, vol.116, pp.4240-4250, 2010.

J. Chen, M. Wang, W. Khan, R. A. He, K. Wang et al., The GSK3? gene confers risk for both major depressive disorder and schizophrenia in the Han Chinese population, J Affect Disord, vol.185, pp.149-155, 2015.

J. H. Chen, K. P. Lin, and Y. C. Chen, Risk factors for dementia, J Formos Med Assoc, vol.108, pp.754-764, 2009.

K. Chen, J. Langbaum, A. S. Fleisher, N. Ayutyanont, C. Reschke et al., Alzheimer's Disease Neuroimaging Initiative (2010) Twelve-month metabolic declines in probable Alzheimer's disease and amnestic mild cognitive impairment assessed using an empirically pre-defined statistical region-of-interest: Findings from the Alzheimer's Disease Neuroimaging Initiative, Neuroimage, vol.51, pp.654-664

Y. Chen, Z. Liang, J. Blanchard, C. L. Dai, S. Sun et al., A nontransgenic mouse model (icv-STZ mouse) of Alzheimer's Disease: Similarities to and differences from the transgenic model (3xTg-AD mouse), Mol Neurobiol, vol.47, pp.1-15, 2013.

Y. Chen, Z. Tian, Z. Liang, S. Sun, C. Dai et al., Brain gene expression of a sporadic (icv-STZ mouse) and a familial mouse model (3xTg-AD mouse) of Alzheimer's Disease, PLoS One, vol.7, pp.1-12, 2012.

Z. Chen and C. Zhong, Decoding Alzheimer's disease from perturbed cerebral glucose metabolism: implications for diagnostic and therapeutic strategies, Prog Neurobiol, vol.108, pp.21-43, 2013.

D. Cheng, J. Noble, M. X. Tang, N. Schupf, R. Mayeux et al., Type 2 diabetes and late-onset Alzheimer's disease, Dement Geriatr Cogn Disord, vol.31, pp.424-430, 2011.

J. Chhatwal and R. Sperling, Functional MRI of Mnemonic Networks across the spectrum of Normal Aging, Mild Cognitive Impairment and Alzheimer's disease, J Alzheimers Dis, vol.31, pp.155-167, 2013.

S. H. Chiang, M. Bazuine, C. N. Lumeng, L. M. Geletka, J. Mowers et al., The protein kinase IKK? regulates energy balance in obese mice, Cell, vol.138, pp.961-975, 2009.

M. A. Chishti, D. S. Yang, J. C. Phinney, A. L. Horne, P. Pearson et al., Early-onset amyloid deposition and cognitive deficits in transgenic mice expressing a double mutant form of amyloid precursor protein 695, J Biol Chem, vol.276, pp.21562-21570, 2001.

Z. Z. Chong, F. Li, and K. Maiese, Stress in the brain: novel cellular mechanisms of injury linked to Alzheimer's disease, Brain Res Brain Res Rev, vol.49, pp.1-21, 2005.

M. Citron, C. Vigo-pelfrey, D. B. Teplow, C. Miller, D. Schenk et al., Excessive production of amyloid beta-protein by peripheral cells of symptomatic and presymptomatic patients carrying the Swedish familial Alzheimer disease mutation, Proc Natl Acad Sci U S A, vol.91, pp.11993-11997, 1994.

J. P. Cleary, D. M. Walsh, J. J. Hofmeister, G. M. Shankar, M. A. Kuskowski et al., Natural oligomers of the amyloid-beta protein specifically disrupt cognitive function, Nat Neurosci, vol.8, pp.79-84, 2005.

L. K. Clinton, L. M. Billings, K. N. Green, A. Caccamo, J. Ngo et al., Age-dependent sexual dimorphism in cognition and stress response in the 3xTg-AD mice, Neurobiol Dis, vol.28, pp.76-82, 2007.

J. A. Cocores and M. S. Gold, The salted food addiction hypothesis may explain overeating and the obesity epidemic, Med Hypotheses, vol.73, pp.892-899, 2009.

N. J. Cohen and L. R. Squire, Preserved learning and retention of pattern-analyzing skill in amnesia: dissociation of knowing how and knowing that, Science, vol.210, pp.207-210, 1980.

S. Colcombe and A. F. Kramer, Fitness effects on the cognitive function of older adults: a meta-analytic study, Psychol Sci, vol.14, pp.125-130, 2003.

A. R. Cole, A. Astell, C. Green, and C. Sutherland, Molecular connexions between dementia and diabetes, Neurosci Biobehav Rev, vol.31, pp.1046-1063, 2007.

A. Contestabile, E. Ciani, and A. Contestabile, Dietary restriction differentially protects from neurodegeneration in animal models of excitotoxicity, Brain Res, vol.1002, pp.162-166, 2004.

M. A. Conway, Episodic memories, Neuropsychologia, vol.47, pp.2305-2313, 2009.

Z. A. Cordner and K. Tamashiro, Effects of high-fat diet exposure on learning and memory, Physiol Behav, vol.152, pp.363-371, 2015.

D. Costa, J. R. Cracchiolo, A. D. Bachstetter, T. F. Hughes, K. R. Bales et al., Enrichment improves cognition in AD mice by amyloid-related and unrelated mechanisms, Neurobiol Aging, vol.28, pp.831-844, 2007.

C. W. Cotman and N. C. Berchtold, Exercise: A behavioral intervention to enhance brain health and plasticity, Trends Neurosci, vol.25, pp.295-301, 2002.

C. W. Cotman, N. C. Berchtold, and L. A. Christie, Exercise builds brain health: key roles of growth factor cascades and inflammation, Trends Neurosci, vol.30, pp.464-472, 2007.

S. E. Counts, M. D. Ikonomovic, N. Mercado, I. E. Vega, and E. J. Mufson, Biomarkers for the early detection and progression of Alzheimer's Disease, pp.1-19, 2016.

J. R. Cracchiolo, T. Mori, S. J. Nazian, J. Tan, H. Potter et al., Enhanced cognitive activity -over and above social or physical activity -is required to protect Alzheimer's mice against cognitive impairment, reduce A? deposition, and increase synaptic immunoreactivity, vol.88, pp.277-294, 2007.

S. Craft, Insulin resistance syndrome and Alzheimer's disease: Age-and obesity-related effects on memory, amyloid, and inflammation, Neurobiol Aging, vol.26, pp.65-69, 2005.

S. Craft, E. Peskind, M. W. Schwartz, G. D. Schellenberg, M. Raskind et al., Cerebrospinal fluid and plasma insulin levels in Alzheimer's disease: relationship to severity of dementia and apolipoprotein E genotype, Neurology, vol.50, pp.164-168, 1998.

L. Crews and E. Masliah, Molecular mechanisms of neurodegeneration in Alzheimer's disease, Hum Mol Genet, vol.19, pp.12-20, 2010.

D. A. Cross, D. R. Alessi, P. Cohen, M. Andjelkovich, and . Hb, Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B, Nature, vol.378, pp.785-789, 1995.

M. Cuadrado-tejedor, J. F. Cabodevilla, M. Zamarbide, T. Gómez-isla, R. Franco et al., Age-related mitochondrial alterations without neuronal loss in the hippocampus of a transgenic model of Alzheimer's disease, Curr Alzheimer Res, vol.10, pp.390-405, 2013.

Y. Cui, Y. Jiao, Y. Chen, K. Wang, B. Gao et al., Altered spontaneous brain activity in type 2 diabetes: a resting-state functional MRI study, Diabetes, vol.63, pp.749-760, 2013.

W. K. Cullen, Y. H. Suh, R. Anwyl, and M. J. Rowan, Block of LTP in rat hippocampus in vivo by beta-amyloid precursor protein fragments, Neuroreport, vol.8, pp.3213-3217, 1997.

S. Cunnane, S. Nugent, M. Roy, A. Courchesne-loyer, E. Croteau et al., Brain fuel metabolism, aging, and Alzheimer's disease, Nutrition, vol.27, pp.3-20, 2011.
URL : https://hal.archives-ouvertes.fr/hal-02309749

M. D'amelio, V. Cavallucci, S. Middei, C. Marchetti, S. Pacioni et al., Caspase-3 triggers early synaptic dysfunction in a mouse model of Alzheimer's disease, Nat Neurosci, vol.14, pp.69-76, 2011.

H. C. Dan, R. J. Antonia, and A. S. Baldwin, PI3K/Akt promotes feedforward mTORC2 activation through IKK?, Oncotarget, vol.7, pp.1-12, 2014.

H. C. Dan, A. Ebbs, M. Pasparakis, T. Dyke, . Van et al., Akt-dependent Activation of mTORC1 Complex Involves Phosphorylation of mTOR ( Mammalian Target of Rapamycin ) by IkB Kinase ? ( IKK?), vol.289, pp.25227-25240, 2014.

P. Das, M. P. Murphy, L. H. Younkin, S. G. Younkin, and T. E. Golde, Reduced effectiveness of Abeta1-42 immunization in APP transgenic mice with significant amyloid deposition, Neurobiol Aging, vol.22, pp.721-727, 2001.

S. R. Datta, H. Dudek, T. Xu, S. Masters, F. Haian et al., Akt phosphorylation of BAD couples survival signals to the cell-intrinsic death machinery, Cell, vol.91, pp.231-241, 1997.

J. Davis, F. Xu, R. Deane, G. Romanov, M. Previti et al., Early-onset and robust cerebral microvascular accumulation of amyloid ?-protein in transgenic mice expressing low levels of a vasculotropic Dutch/Iowa mutant form of amyloid ?-protein precursor, J Biol Chem, vol.279, pp.20296-20306, 2004.

P. C. Davis, M. Gearing, L. Gray, S. S. Mirra, J. C. Morris et al., The CERAD experience, Part VIII: Neuroimaging-neuropathology correlates of temporal lobe changes in Alzheimer's disease, Neurology, vol.45, pp.178-179, 1995.

S. Davis and S. Laroche, What can rodent models tellus about cognitive decline in Alzheimer's Disease?, Mol Neurobiol, vol.27, pp.249-276, 2003.

E. Dawkins and D. H. Small, Insights into the physiological function of the ?-amyloid precursor protein: beyond Alzheimer's disease, J Neurochem, vol.129, pp.756-769, 2014.

R. F. De-bruijn and M. A. Ikram, Cardiovascular risk factors and future risk of Alzheimer's disease, BMC Med, vol.12, pp.1-9, 2014.

F. G. De-felice, Alzheimer's disease and insulin resistance : translating basic science into clinical applications, J Clin Invest, vol.123, pp.531-539, 2013.

F. G. De-felice, M. Vieira, T. R. Bomfim, H. Decker, P. T. Velasco et al., Protection of synapses against Alzheimer's-linked toxins: Insulin signaling prevents the pathogenic binding of A? oligomers, Proc Natl Acad Sci, vol.106, pp.1971-1976, 2009.

S. De-ferranti and D. Mozaffarian, The perfect storm: Obesity, adipocyte dysfunction, and metabolic consequences, Clin Chem, vol.54, pp.945-955, 2008.

S. M. De-la-monte and J. R. Wands, Alzheimer's disease is type 3 diabetes -evidence reviewed, J Diabetes Sci Technol, vol.2, pp.1101-1113, 2008.

D. Sarno, P. Li, X. Jope, and R. S. , Regulation of Akt and glycogen synthase kinase-3? phosphorylation by sodium valproate and lithium, Neuropharmacology, vol.43, pp.1158-1164, 2002.

D. Souza, C. T. Araujo, E. P. Bordin, S. Ashimine, R. Zollner et al., Consumption of a fat-rich diet activates a proinflammatory response and induces insulin resistance in the hypothalamus, Endocrinology, vol.146, pp.4192-4199, 2005.

D. Strooper, B. Saftig, P. Craessaerts, K. Vanderstichele, H. Guhde et al., Deficiency of presenilin-1 inhibits the normal cleavage of amyloid precursor protein, Nature, vol.391, pp.387-390, 1998.

J. Debnath, E. H. Baehrecke, and G. Kroemer, Does autophagy contribute to cell death?, Autophagy, vol.1, pp.66-74, 2005.

M. C. Deeds, J. M. Anderson, A. S. Armstrong, D. A. Gastineau, H. J. Hiddinga et al., Single dose streptozotocin-induced diabetes: considerations for study design in islet transplantation models, Lab Anim, vol.45, pp.131-140, 2011.

R. A. Defronzo, The triumvirate: beta-cell, muscle, liver. A collusion responsible for NIDDM, Diabetes, vol.37, pp.667-687, 1988.

S. Del-rincón, Q. Guo, C. Morelli, H. Shiu, E. Surmacz et al., Retinoic acid mediates degradation of IRS-1 by the ubiquitin-proteasome pathway, via a PKC-dependant mechanism, Oncogene, vol.23, pp.9269-9279, 2004.

D. Heijer, T. Vermeer, S. E. Van-dijk, E. J. Prins, N. D. Koudstaal et al., Type 2 diabetes and atrophy of medial temporal lobe structures on brain MRI, Diabetologia, vol.46, pp.1604-1610, 2003.

B. Deweer, A. M. Ergis, P. Fossati, B. Pillon, F. Boller et al., Explicit memory, procedural learning and lexical priming in Alzheimers disease, Cortex, vol.30, pp.113-126, 1994.

P. Dey, A. Ström, and J. A. Gustafsson, Estrogen receptor ? upregulates FOXO3a and causes induction of apoptosis through PUMA in prostate cancer, Oncogene, vol.33, pp.4213-4225, 2014.

C. Deyts, G. Thinakaran, and A. T. Parent, APP receptor? To be or not to be, Trends Pharmacol Sci, vol.37, pp.390-411, 2016.

S. Díaz-troya, M. E. Pérez-pérez, F. J. Florencio, and J. L. Crespo, The role of TOR in autophagy regulation from yeast to plants and mammals, Autophagy, vol.4, pp.851-865, 2008.

B. C. Dickerson, D. H. Salat, J. F. Bates, M. Atiya, R. J. Killiany et al., Medial temporal lobe function and structure in mild cognitive impairment, Ann Neurol, vol.56, pp.27-35, 2004.

D. W. Dickson, The pathogenesis of senile plaques, J Neuropathol Exp Neurol, vol.56, pp.321-339, 1997.

T. C. Dickson and J. C. Vickers, The morphological phenotype of beta-amyloid plaques and associated neuritic changes in Alzheimer's disease, Neuroscience, vol.105, pp.99-107, 2001.

L. Djoussé, H. Padilla, T. L. Nelson, J. M. Gaziano, and K. J. Mukamal, Diet and metabolic syndrome, Endocr Metab Immune Disord Drug Targets, vol.10, pp.124-137, 2010.

M. Dobarro, G. Gerenu, and M. J. Ramírez, Propranolol reduces cognitive deficits, amyloid and tau pathology in Alzheimer's transgenic mice, Int J Neuropsychopharmacol, vol.16, pp.2245-2257, 2013.

B. W. Doble and J. R. Woodgett, GSK-3: tricks of the trade for a multi-tasking kinase, J Cell Sci, vol.116, pp.1175-1186, 2003.

M. Dobson, G. Ramakrishnan, S. Ma, L. Kaplun, V. Balan et al., Bimodal regulation of FoxO3 by AKT and 14-3-3, Biochim Biophys Acta -Mol Cell Res, vol.1813, pp.1453-1464, 2011.

J. Dodart, K. R. Bales, K. S. Gannon, S. J. Greene, R. B. Demattos et al., Immunization reverses memory deficits without reducing brain Abeta burden in Alzheimer's disease model, Nat Neurosci, vol.5, pp.452-457, 2002.

J. C. Dodart, C. Mathis, and A. Ungerer, The beta-amyloid precursor protein and its derivatives: from biology to learning and memory processes, Rev Neurosci, vol.11, pp.75-93, 2000.

. Donati-a, G. Cavallini, C. Paradiso, S. Vittorini, M. Pollera et al., Age-related changes in the regulation of autophagic proteolysis in rat isolated hepatocytes, J Gerontol A Biol Sci Med Sci, vol.56, pp.288-293, 2001.

J. T. Dourmashkin, G. Q. Chang, J. O. Hill, E. C. Gayles, S. K. Fried et al., Model for predicting and phenotyping at normal weight the long-term propensity for obesity in Sprague-Dawley rats, Physiol Behav, vol.87, pp.666-678, 2006.

D. Drago, M. Bettella, S. Bolognin, L. Cendron, J. Scancar et al., Potential pathogenic role of ?-amyloid1-42-aluminum complex in Alzheimer's disease, Int J Biochem Cell Biol, vol.40, pp.731-746, 2008.

R. Dringen, R. Gebhardt, and B. Hamprecht, Glycogen in astrocytes: possible function as lactate supply for neighboring cells, Brain Res, vol.623, pp.208-214, 1993.

A. I. Duarte, P. I. Moreira, and C. R. Oliveira, Insulin in central nervous system: More than just a peripheral hormone, J Aging Res, 2012.

A. I. Duarte, P. Santos, C. R. Oliveira, M. S. Santos, and A. C. Rego, Insulin neuroprotection against oxidative stress is mediated by Akt and GSK-3? signaling pathways and changes in protein expression, Biochim Biophys Acta -Mol Cell Res, vol.1783, pp.994-1002, 2008.

K. Duff, C. Eckman, C. Zehr, X. Yu, C. M. Prada et al., Increased amyloid-?42(43) in brains of mice expressing mutant presenilin 1, Nature, vol.383, pp.710-713, 1996.

A. M. Duffy and C. Hölscher, The incretin analogue D-Ala2GIP reduces plaque load, astrogliosis and oxidative stress in an APP/PS1 mouse model of Alzheimer's disease, Neuroscience, vol.228, pp.294-300, 2013.

F. Dulin, F. Léveillé, J. B. Ortega, J. Mornon, A. Buisson et al., P3 peptide, a truncated form of A beta devoid of synaptotoxic effect, does not assemble into soluble oligomers, FEBS Lett, vol.582, pp.1865-1870, 2008.

S. B. Dunnett, The role and repair of forebrain cholinergic systems in short-term memory. Studies using the delayed matching-to-position task in rats, Adv Neurol, vol.59, pp.53-65, 1993.

J. Ekstrand, J. Hellsten, and A. Tingström, Environmental enrichment , exercise and corticosterone affect endothelial cell proliferation in adult rat hippocampus and prefrontal cortex, vol.442, pp.203-207, 2008.

H. Eldar-finkelman and O. Kaidanovich, The role of glycogen synthase kinase-3 in insulin resistance and Type 2 diabetes, Expert Opin Ther Targets, vol.6, pp.555-561, 2002.

H. Eldar-finkelman, R. Seger, J. R. Vandenheede, and E. G. Krebs, Inactivation of glycogen synthase kinase-3 by epidermal growth factor is mediated by mitogen-activated protein kinase/p90 ribosomal protein S6 kinase signaling pathway in NIH/3T3 cells, J Biol Chem, vol.270, pp.987-990, 1995.

G. A. Elder, G. Sosa, M. A. , D. Gasperi, and R. , Transgenic mouse models of Alzheimer's Disease, Mt Sinai J Med, vol.77, pp.69-81, 2010.

S. Elmore, Apoptosis: a review of programmed cell death, Toxicol Pathol, vol.35, pp.495-516, 2007.

M. J. Engelhart, M. I. Geerlings, J. Meijer, A. Kiliaan, A. Ruitenberg et al., Inflammatory proteins in plasma and the risk of dementia: the rotterdam study, Arch Neurol, vol.61, pp.668-672, 2004.

H. Engler, A. Forsberg, O. Almkvist, G. Blomquist, E. Larsson et al., Two-year follow-up of amyloid deposition in patients with Alzheimer's disease, Brain, vol.129, pp.2856-2866, 2006.

A. Ennaceur and K. Meliani, A new one-trial test for neurobiological studies of memory in rats. III. Spatial vs. nonspatial working memory, Behav Brain Res, vol.51, pp.83-92, 1992.

F. Erd?, L. Denes, and E. De-lange, Age-associated physiological and pathological changes at the blood-brain barrier: A review, J Cereb Blood Flow, vol.37, pp.4-24, 2016.

K. I. Erickson, R. L. Leckie, and A. M. Weinstein, Physical activity, fitness, and gray matter volume, Neurobiol Aging, vol.35, pp.20-28, 2014.

K. I. Erickson, M. W. Voss, R. S. Prakash, C. Basak, A. Szabo et al., Exercise training increases size of hippocampus and improves memory, Proc Natl Acad Sci U S A, vol.108, pp.3017-3022, 2011.

A. Erol, An integrated and unifying hypothesis for the metabolic basis of sporadic Alzheimer's Disease, J Alzheimers Dis, vol.13, pp.241-253, 2008.

D. Erten-lyons, R. L. Woltjer, H. Dodge, R. Nixon, R. Vorobik et al., Factors associated with resistance to dementia despite high Alzheimer disease pathology, Neurology, vol.72, pp.354-360, 2009.

M. J. Eslamizade, Z. Madjd, H. Rasoolijazi, F. Saffarzadeh, V. Pirhajati et al., Impaired memory and evidence of histopathology in CA1 pyramidal neurons through injection of A?1-42 peptides into the frontal cortices of rat, Basic Clin Neurosci, vol.7, pp.31-42, 2016.

M. A. Espeland, R. N. Bryan, J. S. Goveas, J. G. Robinson, M. S. Siddiqui et al., Influence of type 2 diabetes on brain volumes and changes in brain volumes: Results from the Women's Health Initiative Magnetic Resonance Imaging Studies, Diabetes Care, vol.36, pp.90-97, 2013.

M. Esteve, I. Rafecas, J. Fernández-lópez, X. Remesar, and M. Alemany, Effect of a cafeteria diet on energy intake and balance in Wistar rats, Physiol Behav, vol.56, pp.65-71, 1994.

M. Ewers, P. S. Insel, Y. Stern, and M. W. Weiner, Alzheimer's Disease Neuroimaging Initiative (ADNI) (2013) Cognitive reserve associated with FDG-PET in preclinical Alzheimer disease, Neurology, vol.80, pp.1194-1201

K. Fabel, B. Tam, D. Kaufer, A. Baiker, N. Simmons et al., VEGF is necessary for exercise, Eur J Neurosci, vol.18, pp.2803-2812, 2003.

A. M. Fagan, C. Xiong, M. S. Jasielec, R. J. Bateman, A. M. Goate et al., Longitudinal change in CSF biomarkers in autosomal-dominant Alzheimer's disease, Sci Transl Med, vol.6, pp.226-230, 2014.

A. M. Fagan, M. A. Mintun, R. H. Mach, S. Lee, C. S. Dence et al., Inverse relation between in vivo amyloid imaging load and cerebrospinal fluid A?42 in humans, Ann Neurol, vol.59, pp.512-519, 2006.

H. Fakhrai-rad, N. A. Kamel-a, M. Fernström, J. R. Zierath, S. Norgren et al., Insulindegrading enzyme identified as a candidate diabetes susceptibility gene in GK rats, Hum Mol Genet, vol.9, pp.2149-2158, 2000.

R. S. Falck, J. C. Davis, and T. Liu-ambrose, What is the association between sedentary behaviour and cognitive function? A systematic review, Br J Sports Med bjsports, pp.2015-095551, 2016.

X. Fang, S. X. Yu, Y. Lu, R. C. Bast, J. R. Woodgett et al., Phosphorylation and inactivation of glycogen synthase kinase 3 by protein kinase A, Proc Natl Acad Sci U S A, vol.97, pp.11960-11965, 2000.

J. Farmer, X. Zhao, H. Van-praag, K. Wodtke, F. H. Gage et al., Effects of voluntary exercise on synaptic plasticity and gene expression in the dentate gyrus of adult male sprague-dawley rats in vivo, Neuroscience, vol.124, pp.71-79, 2004.

W. Farris, S. Mansourian, Y. Chang, L. Lindsley, E. A. Eckman et al., Insulin-degrading enzyme regulates the levels of insulin, amyloid beta-protein, and the beta-amyloid precursor protein intracellular domain in vivo, Proc Natl Acad Sci U S A, vol.100, pp.4162-4167, 2003.

H. Feldman and N. Qadi, Addressing severe Alzheimer's Disease: A clinical approach, Can Rev Alzheimer' s Dis other Dementias, vol.8, pp.4-9, 2006.

M. Ferreira-marques, C. A. Aveleira, S. Carmo-silva, M. Botelho, L. Pereira-de-almeida et al., Caloric restriction stimulates autophagy in rat cortical neurons through neuropeptide Y and ghrelin receptors activation, Aging (Albany NY), vol.8, pp.1470-1484, 2016.

L. K. Ferreira, J. H. Tamashiro-duran, P. Squarzoni, F. L. Duran, T. C. Alves et al., The link between cardiovascular risk, alzheimer's disease, and mild cognitive impairment: Support from recent functional neuroimaging studies, Rev Bras Psiquiatr, vol.36, pp.344-357, 2014.

J. C. Fiala, M. Feinberg, A. Peters, and H. Barbas, Mitochondrial degeneration in dystrophic neurites of senile plaques may lead to extracellular deposition of fine filaments, Brain Struct Funct, vol.212, pp.195-207, 2007.

N. Filippini, M. Zarei, C. F. Beckmann, S. Galluzzi, G. Borsci et al., Regional atrophy of transcallosal prefrontal connections in cognitively normal APOE ?4 carriers, J Magn Reson Imaging, vol.29, pp.1021-1026, 2009.

S. M. Fitzjohn, R. A. Morton, F. Kuenzi, T. W. Rosahl, M. Shearman et al., Age-related impairment of synaptic transmission but normal long-term potentiation in transgenic mice that overexpress the human APP695SWE mutant form of amyloid precursor protein, J Neurosci, vol.21, pp.4691-4698, 2001.

A. S. Fleisher, W. S. Houston, L. T. Eyler, S. Frye, C. Jenkins et al., Identification of Alzheimer Disease risk by functional magnetic resonance imaging, Arch Neurol, vol.62, p.1881, 2005.

D. G. Flood, A. G. Reaume, K. S. Dorfman, Y. G. Lin, D. M. Lang et al., FAD mutant PS-1 gene-targeted mice: Increased A?42 and A? deposition without APP overproduction, Neurobiol Aging, vol.23, pp.335-348, 2002.

L. Fontana, L. Partridge, and V. D. Longo, Extending healthy life span--From yeast to humans, Science, vol.328, pp.321-326, 2010.

F. Forette, M. Seux, J. A. Staessen, L. Thijs, M. Babarskiene et al., Systolic Hypertension in Europe Investigators (2002) The prevention of dementia with antihypertensive treatment: new evidence from the Systolic Hypertension in Europe (Syst-Eur) study, Arch Intern Med, vol.162, pp.2046-2052

O. V. Forlenza, C. A. Torres, L. L. Talib, V. J. De-paula, H. Joaquim et al., Increased platelet GSK3B activity in patients with mild cognitive impairment and Alzheimer's disease, J Psychiatr Res, vol.45, pp.220-224, 2011.

P. Formichi, C. Battisti, E. Radi, and A. Federico, Cerebrospinal fluid tau, A beta, and phosphorylated tau protein for the diagnosis of Alzheimer's disease, J Cell Physiol, vol.208, pp.39-46, 2006.

T. C. Foster, H. N. Fugger, and S. G. Cunningham, Receptor blockade reveals a correspondence between hippocampaldependent behavior and experience-dependent synaptic enhancement, Brain Res, vol.871, pp.39-43, 2000.

S. A. Frautschy and G. M. Cole, Why pleiotropic interventions are needed for Alzheimer's Disease, Mol Neurobiol, vol.41, pp.392-409, 2010.

S. Freude, L. Plum, J. Schnitker, U. Leeser, M. Udelhoven et al., Peripheral hyperinsulinemia promotes Tau phosphorylation in vivo, Diabetes, vol.7, pp.305-308, 2005.

A. J. Furst, G. D. Rabinovici, A. H. Rostomian, T. Steed, A. Alkalay et al., Cognition, glucose metabolism and amyloid burden in Alzheimer's disease, Neurobiol Aging, vol.33, pp.215-225, 2012.

K. Furukawa, B. L. Sopher, R. E. Rydel, J. G. Begley, D. G. Pham et al., Increased activityregulating and neuroprotective efficacy of alpha-secretase-derived secreted amyloid precursor protein conferred by a C-terminal heparin-binding domain, J Neurochem, vol.67, pp.1882-1896, 1996.

J. Fuss, S. Biedermann, C. Falfán-melgoza, M. K. Auer, L. Zheng et al., Exercise boosts hippocampal volume by preventing early age-related gray matter loss, Hippocampus, vol.24, pp.131-134, 2014.

L. Galluzzi, A. López-soto, S. Kumar, and G. Kroemer, Caspases connect cell-death signaling to organismal homeostasis, Immunity, vol.44, pp.221-231, 2016.

D. Games, D. Adams, R. Alessandrini, R. Barbour, P. Berthelette et al., Alzheimer-type neuropathology in transgenic mice overexpressing V717F ?-amyloid precursor protein, Nature, vol.373, pp.523-527, 1995.

Y. García-mesa, J. C. López-ramos, L. Giménez-llort, S. Revilla, R. Guerra et al., Physical exercise protects against Alzheimer's disease in 3xTg-AD mice, J Alzheimer's Dis, vol.24, pp.421-454, 2011.

A. Garcia-osta and C. M. Alberini, Amyloid beta mediates memory formation, Learn Mem, vol.16, pp.267-272, 2009.

C. Garcia, B. Feve, P. Ferré, S. Halimi, H. Baizri et al., Diabetes and inflammation: fundamental aspects and clinical implications, Diabetes Metab, vol.36, pp.327-338, 2010.

L. Gasparini, G. K. Gouras, R. Wang, R. S. Gross, M. F. Beal et al., Stimulation of beta-amyloid precursor protein trafficking by insulin reduces intraneuronal beta-amyloid and requires mitogen-activated protein kinase signaling, J Neurosci, vol.21, pp.2561-2570, 2001.

M. C. Gastard, J. C. Troncoso, and V. E. Koliatsos, Caspase activation in the limbic cortex of subjects with early Alzheimer's disease, Ann Neurol, vol.54, pp.393-398, 2003.

A. N. Gearhardt, C. Davis, R. Kuschner, and K. D. Brownell, The addiction potential of hyperpalatable foods, Curr Drug Abuse Rev, vol.4, pp.140-145, 2011.

S. Gengler, A. Hamilton, and C. Hölscher, Synaptic plasticity in the hippocampus of a APP/PS1 mouse model of Alzheimer's Disease is impaired in old but not young mice, PLoS One, vol.5, pp.1-10, 2010.

J. Giacchino, J. R. Criado, D. Games, and S. Henriksen, In vivo synaptic transmission in young and aged amyloid precursor protein transgenic mice, Brain Res, vol.876, pp.185-190, 2000.

P. F. Giannopoulos, J. Chu, Y. B. Joshi, M. Sperow, J. G. Li et al., Gene knockout of 5-lipoxygenase rescues synaptic dysfunction and improves memory in the triple-transgenic model of Alzheimer's disease, vol.33, pp.395-401, 2014.

B. Giffard, M. Laisney, F. Mezenge, V. De-la-sayette, F. Eustache et al., The neural substrates of semantic memory deficits in early Alzheimer's disease: Clues from semantic priming effects and FDG-PET, Neuropsychologia, vol.46, pp.1657-1666, 2008.

S. Gillette-guyonnet and B. Vellas, Caloric restriction and brain function, Curr Opin Clin Nutr Metab Care, vol.11, pp.686-692, 2008.

L. Giménez-llort, G. Blázquez, T. Cañete, B. Johansson, S. Oddo et al., Modeling behavioral and neuronal symptoms of Alzheimer's disease in mice: a role for intraneuronal amyloid, Neurosci Biobehav Rev, vol.31, pp.125-147, 2007.

C. G. Glabe, Structural classification of toxic amyloid oligomers, J Biol Chem, vol.283, pp.29639-29643, 2008.

G. G. Glenner and C. W. Wong, Alzheimer's disease: Initial report of the purification and characterization of a novel cerebrovascular amyloid protein, Biochem Biophys Res Commun, vol.120, pp.885-890, 1984.

D. Glick, S. Barth, and K. F. Macleod, Autophagy : cellular and molecular mechanisms, J Pathol, vol.221, pp.3-12, 2010.

M. Goedert and B. Ghetti, Alois Alzheimer: His life and times, Brain Pathol, vol.17, pp.57-62, 2007.

M. Goedert and M. G. Spillantini, A century of Alzheimer's disease, Science, vol.314, pp.777-781, 2006.

A. Golay, J. P. Felber, E. Jequier, R. A. Defronzo, and E. Ferrannini, Metabolic basis of obesity and noninsulin-dependent diabetes mellitus, Diabetes Metab Rev, vol.4, pp.727-747, 1988.

T. E. Golde, S. Estus, L. H. Younkin, D. J. Selkoe, and S. G. Younkin, Processing of the amyloid protein precursor to potentially amyloidogenic derivatives, Science, vol.255, pp.728-730, 1992.

T. Gomez-isla, R. Hollister, H. West, S. Mui, J. H. Growdon et al., Neuronl Loss Correlates with but Exceeds Neurofibrillary Tangles in Alzheimer 's Disease, vol.41, pp.17-24, 1997.

T. Gómez-isla, J. L. Price, D. W. Mckeel, J. C. Morris, J. H. Growdon et al., Profound loss of layer II entorhinal cortex neurons occurs in very mild Alzheimer's disease, J Neurosci, vol.16, pp.4491-4500, 1996.

B. Gong, O. Vitolo, F. Trinchese, S. Liu, and M. Shelanski, Persistent improvement in synaptic and cognitive functions in an Alzheimer mouse model after rolipram treatment, J Clin Invest, vol.114, 2004.

M. Gorska-ciebiada, M. Saryusz-wolska, M. Ciebiada, and J. Loba, Mild cognitive impairment and depressive symptoms in elderly patients with diabetes: prevalence, risk factors, and comorbidity, J Diabetes Res, p.179648, 2014.

T. D. Gould and H. K. Manji, The Wnt signaling pathway in bipolar disorder, Neuroscientist, vol.8, pp.497-511, 2002.

E. Gowing, A. E. Roher, A. S. Woods, R. J. Cotter, M. Chaney et al., Chemical characterization of A beta 17-42 peptide, a component of diffuse amyloid deposits of Alzheimer disease, J Biol Chem, vol.269, pp.10987-10990, 1994.

P. Grieb, Intracerebroventricular Streptozotocin injections as a model of Alzheimer's Disease: in search of a relevant mechanism, Mol Neurobiol, vol.53, pp.1741-1752, 2016.

C. A. Grillo, G. G. Piroli, L. Junor, S. P. Wilson, D. D. Mott et al., Obesity/hyperleptinemic phenotype impairs structural and functional plasticity in the rat hippocampus, Physiol Behav, vol.105, pp.138-144, 2011.

I. Grundke-iqbal, K. Iqbal, Y. C. Tung, M. Quinlan, H. M. Wisniewski et al., Abnormal phosphorylation of the microtubule-associated protein tau (tau) in Alzheimer cytoskeletal pathology, Proc Natl Acad Sci, vol.83, pp.4913-4917, 1986.

P. Gual, L. Marchand-brustel, Y. Tanti, and J. , Positive and negative regulation of insulin signaling through IRS-1 phosphorylation, Biochimie, vol.87, pp.99-109, 2005.

Q. Guo, W. Fu, B. L. Sopher, M. W. Miller, C. B. Ware et al., Increased vulnerability of hippocampal neurons to excitotoxic necrosis in presenilin-1 mutant knock-in mice, Nat Med, vol.5, pp.101-106, 1999.

I. Gureviciene, S. Ikonen, K. Gurevicius, A. Sarkaki, T. Van-groen et al., Normal induction but accelerated decay of LTP in APP + PS1 transgenic mice, Neurobiol Dis, vol.15, pp.188-195, 2004.

C. Haass, A. Y. Hung, and D. J. Selkoe, Processing of beta-amyloid precursor protein in microglia and astrocytes favors an internal localization over constitutive secretion, J Neurosci, vol.11, pp.3783-3793, 1991.

C. Haass, C. Kaether, G. Thinakaran, and S. Sisodia, Trafficking and Proteolytic Processing of APP.pdf. Cold Spring Harb Perspect Med, pp.1-26, 2012.

C. Haass, E. H. Koo, A. Mellon, A. Y. Hung, and D. J. Selkoe, Targeting of cell-surface beta-amyloid precursor protein to lysosomes: alternative processing into amyloid-bearing fragments, Nature, vol.357, pp.500-503, 1992.

S. L. Habib and S. Liang, Hyperactivation of Akt/mTOR and deficiency in tuberin increased the oxidative DNA damage in kidney cancer patients with diabetes, Oncotarget, vol.5, pp.2542-2550, 2014.

J. Hagenbuchner, K. A. Hermann, M. Hausott, B. Obexer, P. Ausserlechner et al., FOXO3-induced reactive oxygen species are regulated by BCL2L11 (Bim) and SESN3, J Cell Sci, vol.125, pp.1191-1203, 2012.

A. E. Hak, H. Pols, C. Stehouwer, J. Meijer, A. J. Kiliaan et al., Markers of iinflammation and cellular adhesion molecules in relation to insulin resistance in nondiabetic elderly : The Rotterdam study, J Clin Endocrinol Metab, vol.86, pp.4398-4405, 2001.

V. Halagappa, Z. Guo, M. Pearson, Y. Matsuoka, R. G. Cutler et al., Intermittent fasting and caloric restriction ameliorate age-related behavioral deficits in the triple-transgenic mouse model of Alzheimer's disease, Neurobiol Dis, vol.26, pp.212-220, 2007.

C. N. Hales and D. Barker, Type 2 (non-insulin-dependent) diabetes mellitus: the thrifty phenotype hypothesis, Int J Epidemiol, vol.42, pp.1215-1222, 2013.

M. Hamer and Y. Chida, Physical activity and risk of neurodegenerative disease: a systematic review of prospective evidence, Psychol Med, vol.39, pp.3-11, 2009.

L. K. Hamilton, A. Aumont, C. Julien, A. Vadnais, F. Calon et al., Widespread deficits in adult neurogenesis precede plaque and tangle formation in the 3xTg mouse model of Alzheimer's disease, Eur J Neurosci, vol.32, pp.905-920, 2010.

H. Hampel, D. Prvulovic, S. Teipel, F. Jessen, C. Luckhaus et al., German Task Force on Alzheimer's Disease (GTF-AD) (2011) The future of Alzheimer's disease: The next 10 years, Prog Neurobiol, vol.95, pp.718-728

A. J. Hannan, Review: Environmental enrichment and brain repair: Harnessing the therapeutic effects of cognitive stimulation and physical activity to enhance experience-dependent plasticity, Neuropathol Appl Neurobiol, vol.40, pp.13-25, 2014.

R. A. Hansen, G. Gartlehner, A. P. Webb, L. C. Morgan, C. G. Moore et al., Efficacy and safety of donepezil , galantamine , and rivastigmine for the treatment of Alzheimer ' s disease : A systematic review and meta-analysis, Clin Interv Aging, vol.3, pp.211-225, 2008.

L. L. Harburger, T. J. Lambert, K. M. Frick, I. N. Program, and N. Haven, Age-dependent effects of environmental enrichment on spatial reference memory in male mice, vol.185, pp.43-48, 2007.

J. A. Hardy and G. A. Higgins, Alzheimer's disease: the amyloid cascade hypothesis, Science, vol.256, pp.184-185, 1992.

S. I. Harik, R. N. Kalaria, L. Andersson, P. Lundahl, and G. Perry, Immunocytochemical localization of the erythroid glucose transporter: abundance in tissues with barrier functions, J Neurosci, vol.10, pp.3862-3872, 1990.

N. Hariri and L. Thibault, High-fat diet-induced obesity in animal models, Nutr Res Rev, vol.23, pp.270-299, 2010.

J. A. Harrold, G. Williams, and P. S. Widdowson, Early leptin response to a palatable diet predicts dietary obesity in rats: key role of melanocortin-4 receptors in the ventromedial hypothalamic nucleus, J Neurochem, vol.74, pp.1224-1228, 2000.

R. E. Hartman, Y. Izumi, K. R. Bales, S. M. Paul, D. F. Wozniak et al., Treatment with an amyloid-beta antibody ameliorates plaque load, learning deficits, and hippocampal long-term potentiation in a mouse model of Alzheimer's disease, J Neurosci, vol.25, pp.6213-6220, 2005.

J. Havrankova, J. Roth, and M. Brownstein, Insulin receptors are widely distributed in the central nervous system of the rat, Nature, vol.272, pp.827-829, 1978.

T. Hedden, K. Dijk, . Van, J. A. Becker, A. Mehta et al., Older Adults Harboring Amyloid Burden, J Neurosci, vol.29, pp.12686-12694, 2009.

W. C. Heindel, D. P. Salmon, C. W. Shults, P. A. Walicke, and N. Butters, Neuropsychological evidence for multiple implicit memory systems: a comparison of Alzheimer's, Huntington's, and Parkinson's disease patients, J Neurosci, vol.9, pp.582-587, 1989.

K. Heininger, A unifying hypothesis of Alzheimer's disease. II. Pathophysiological processes, Hum Psychopharmacol Clin Exp, vol.14, pp.525-581, 1999.

D. Heras-sandoval, J. M. Pérez-rojas, J. Hernández-damián, and J. Pedraza-chaverri, The role of PI3K/AKT/mTOR pathway in the modulation of autophagy and the clearance of protein aggregates in neurodegeneration, Cell Signal, vol.26, pp.2694-2701, 2014.

A. Herring, H. Yasin, O. Ambrée, N. Sachser, W. Paulus et al., Environmental Enrichment Counteracts Alzheimer ' s Neurovascular Dysfunction in TgCRND8 Mice, vol.18, pp.32-39, 2008.

K. Herrup, Reimagining Alzheimer's Disease--an age-based hypothesis, J Neurosci, vol.30, pp.16755-16762, 2010.

K. Herrup, The case for rejecting the amyloid cascade hypothesis, Nat Neurosci, vol.18, pp.794-799, 2015.

K. Herrup, M. C. Carrillo, D. Schenk, A. Cacace, S. Desanti et al., Beyond amyloid: Getting real about nonamyloid targets in Alzheimer's disease, Alzheimers Dement, vol.9, pp.452-458, 2013.

L. Hesse, D. Beher, C. L. Masters, and G. Multhaup, The beta A4 amyloid precursor protein binding to copper, FEBS Lett, vol.349, pp.109-116, 1994.

A. Heydemann, An overview of murine high fat diet as a model for Type 2 Diabetes Mellitus, J Diabetes Res, 2016.

P. Heyn, B. C. Abreu, and K. J. Ottenbacher, The effects of exercise training on elderly persons with cognitive impairment and dementia: A meta-analysis, Arch Phys Med Rehabil, vol.85, pp.1694-1704, 2004.

F. D. Heyward, R. G. Walton, M. S. Carle, M. A. Coleman, W. T. Garvey et al., Adult mice maintained on a high-fat diet exhibit object location memory deficits and reduced hippocampal SIRT1 gene expression, Neurobiol Learn Mem, vol.98, pp.25-32, 2012.

L. S. Higgins, G. M. Murphy, L. S. Forno, R. Catalano, and B. Cordell, P3 beta-amyloid peptide has a unique and potentially pathogenic immunohistochemical profile in Alzheimer's disease brain, Am J Pathol, vol.149, pp.585-596, 1996.

A. L. Hildebrandt, D. M. Kelly-sullivan, and S. C. Black, Antiobesity effects of chronic cannabinoid CB1 receptor antagonist treatment in diet-induced obese mice, Eur J Pharmacol, vol.462, pp.125-132, 2003.

M. Hinz and C. Scheidereit, The I kappa B kinase complex in NF-kappa B regulation and beyond, EMBO Rep, vol.15, pp.46-61, 2014.

K. Hirai, G. Aliev, A. Nunomura, H. Fujioka, R. L. Russell et al., Mitochondrial abnormalities in Alzheimer's disease, J Neurosci, vol.21, pp.3017-3023, 2001.

L. Ho, W. Qin, P. N. Pompl, Z. Xiang, J. Wang et al., Diet-induced insulin resistance promotes amyloidosis in a transgenic mouse model of Alzheimer's disease, Faseb J, vol.18, pp.902-904, 2004.

J. R. Hodges, D. P. Salmon, and N. Butters, Semantic memory impairment in Alzheimer's Disease : Failure of access or degraded Knowledge ? Newopsychologi, vol.30, pp.301-314, 1992.

L. A. Holcomb, M. N. Gordon, P. Jantzen, K. Hsiao, K. Duff et al., Behavioral changes in transgenic mice expressing both amyloid precursor protein and presenilin-1 mutations: Lack of association with amyloid deposits, Behav Genet, vol.29, pp.177-185, 1999.

L. Holcomb, M. N. Gordon, E. Mcgowan, X. Yu, S. Benkovic et al., , 1998.

, type phenotype in transgenic mice carrying both mutant amyloid precursor protein and presenilin 1 transgenes, Nat Med, vol.4, pp.97-100

C. Holmes, D. Boche, D. Wilkinson, G. Yadegarfar, V. Hopkins et al., Long-term effects of A?42 immunisation in Alzheimer's disease: follow-up of a randomised, placebo-controlled phase I trial, Lancet, vol.372, pp.216-223, 2008.

C. Hommet, K. Mondon, V. Camus, M. J. Ribeiro, E. Beaufils et al., Neuroinflammation and beta amyloid deposition in Alzheimer's disease: in vivo quantification with molecular imaging, Dement Geriatr Cogn Disord, vol.37, pp.1-18, 2014.

N. Hori, I. Hirotsu, P. J. Davis, and D. O. Carpenter, Long-term potentiation is lost in aged rats but preserved by calorie restriction, Neuroreport, vol.3, pp.1085-1088, 1992.

J. M. Horwood, F. Dufour, S. Laroche, and S. Davis, Signalling mechanisms mediated by the phosphoinositide 3-kinase/Akt cascade in synaptic plasticity and memory in the rat, Eur J Neurosci, vol.23, pp.3375-3384, 2006.

C. Howarth, P. Gleeson, and D. Attwell, Updated energy budgets for neural computation in the neocortex and cerebellum, J Cereb blood flow Metab, vol.32, pp.1222-1232, 2012.

K. Hsiao, P. Chapman, S. Nilsen, C. Eckman, Y. Harigaya et al., Amyloid plaques in transgenic mice, vol.274, pp.7-10, 1996.

M. Hu, D. Lee, W. Xia, L. S. Golfman, F. Ou-yang et al., IkappaB kinase promotes tumorigenesis through inhibition of forkhead FOXO3a, Cell, vol.117, pp.225-237, 2004.

A. R. Humphrey, D. J. Mccarty, I. R. Mackay, M. J. Rowley, T. Dwyer et al., Autoantibodies to glutamic acid decarboxylase and phenotypic features associated with early insulin treatment in individuals with adult-onset diabetes mellitus, Diabet Med, vol.15, pp.113-119, 1998.

Y. H. Hung, A. I. Bush, and R. A. Cherny, Copper in the brain and Alzheimer's disease, JBIC J Biol Inorg Chem, vol.15, pp.61-76, 2010.

I. Hussain, D. Powell, D. R. Howlett, D. G. Tew, T. D. Meek et al., Identification of a Novel Aspartic Protease (Asp 2) as ?-Secretase, Mol Cell Neurosci, vol.14, pp.419-427, 1999.

M. Hüttenrauch, A. Brauß, A. Kurdakova, H. Borgers, F. Klinker et al., Physical activity delays hippocampal neurodegeneration and rescues memory deficits in an Alzheimer disease mouse model, Transl Psychiatry, vol.6, p.800, 2016.

A. Hye, F. Kerr, N. Archer, C. Foy, M. Poppe et al., Glycogen synthase kinase-3 is increased in white cells early in Alzheimer's disease, Neurosci Lett, vol.373, pp.1-4, 2005.

F. Idrobo, K. Nandy, D. I. Mostofsky, L. Blatt, and L. Nandy, Dietary restriction: effects on radial maze learning and lipofuscin pigment deposition in the hippocampus and frontal cortex, Arch Gerontol Geriatr, vol.6, pp.355-362, 1987.

M. Ingelsson, H. Fukumoto, K. L. Newell, J. H. Growdon, E. T. Hedley-whyte et al., Early Abeta accumulation and progressive synaptic loss, gliosis, and tangle formation in AD brain, Neurology, vol.62, pp.925-931, 2004.

D. J. Ingle, A simple means of producing obesity in the rat, Proc Soc Exp Biol Med, vol.72, p.604, 1949.

M. Irizarry, M. Mcnamara, K. Hsiao, K. Hyman, and B. , APPSw transgenic mice develop age-related A? deposits and neuropil abnormalities, but no neuronal loss in CA1, J Neuropathol Exp Neurol, vol.56, pp.965-973, 1997.

A. G. Isla, F. G. Vázquez-cuevas, and F. Peña-ortega, Exercise prevents amyloid-?-induced hippocampal network disruption by inhibiting GSK3? activation, J Alzheimers Dis, vol.52, pp.333-343, 2016.

S. Itagaki, P. L. Mcgeer, H. Akiyama, S. Zhu, and D. Selkoe, Relationship of microglia and astrocytes to amyloid deposits of Alzheimer disease, J Neuroimmunol, vol.24, pp.173-182, 1989.

M. Ito, Y. Kondo, A. Nakatani, K. Hayashi, and A. Naruse, Characterization of low dose streptozotocin-induced progressive diabetes in mice, Environ Toxicol Pharmacol, vol.9, pp.71-78, 2001.

H. Iwasa, Y. Yoshida, K. I. Suzuki, T. Kim, H. Yoshida et al., Leisure activities and cognitive function in elderly community-dwelling individuals in Japan: A 5-year prospective cohort study, J Psychosom Res, vol.72, pp.159-164, 2012.

T. Iwatsubo, T. C. Saido, D. M. Mann, V. M. Lee, and J. Q. Trojanowski, Full-length amyloid-beta (1-42(43)) and aminoterminally modified and truncated amyloid-beta 42(43) deposit in diffuse plaques, Am J Pathol, vol.149, pp.1823-1830, 1996.

C. R. Jack, J. R. Barrio, and V. Kepe, Cerebral amyloid PET imaging in Alzheimer's disease, Acta Neuropathol, vol.126, pp.643-657, 2013.

C. R. Jack, D. S. Knopman, W. J. Jagust, L. M. Shaw, P. S. Aisen et al., Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade, Lancet Neurol, vol.9, pp.119-128, 2010.

C. R. Jack, V. J. Lowe, S. D. Weigand, H. J. Wiste, M. L. Senjem et al., Alzheimer's Disease Neuroimaging Initiative (2009) Serial PIB and MRI in normal, mild cognitive impairment and Alzheimer's disease: implications for sequence of pathological events in Alzheimer's disease, Brain, vol.132, pp.1355-1365

J. S. Jacobsen, C. Wu, J. M. Redwine, T. A. Comery, R. Arias et al., Early-onset behavioral and synaptic deficits in a mouse model of Alzheimer's disease, Proc Natl Acad Sci, vol.103, pp.5161-5166, 2006.

I. Jalloh, K. Carpenter, A. Helmy, T. A. Carpenter, D. K. Menon et al., Glucose metabolism following human traumatic brain injury: methods of assessment and pathophysiological findings, Metab Brain Dis, vol.30, pp.615-632, 2015.

J. L. Jankowsky, T. Melnikova, D. J. Fadale, G. M. Xu, H. H. Slunt et al., Environmental enrichment mitigates cognitive deficits in a mouse model of Alzheimer's disease, J Neurosci, vol.25, pp.5217-5224, 2005.

J. Janson, T. Laedtke, J. E. Parisi, P. O'brien, R. C. Petersen et al., Increased risk of type 2 diabetes in Alzheimer disease, Diabetes, vol.53, pp.474-481, 2004.

C. Janus and J. Pm-m, A? peptide immunization reduces behavioural impairment and plaques in a model of Alzheimer's disease, vol.334, 1998.

J. T. Jarrett and P. T. Lansburry, Seeding "one dimensional cristallization" of amyloid: a pathogenic mechanism in Alzheimer's disease and scrapie, Cell, vol.73, pp.1055-1058, 1993.

K. A. Jellinger, The pathology of "vascular dementia": A critical update, J Alzheimers Dis, vol.14, pp.107-123, 2008.

L. E. Jensen, G. Bultynck, T. Luyten, H. Amijee, M. D. Bootman et al., Alzheimer's disease-associated peptide A?42 mobilizes ER Ca(2+) via InsP3R-dependent and -independent mechanisms, Front Mol Neurosci, pp.6-36, 2013.

B. T. Jeon, E. A. Jeong, H. J. Shin, Y. Lee, D. H. Lee et al., Resveratrol attenuates obesity-associated peripheral and central inflammation and improves memory deficit in mice fed a high-fat diet, Diabetes, vol.61, pp.1444-1454, 2012.

J. L. Jewell and K. L. Guan, Nutrient signaling to mTOR and cell growth, Trends Biochem Sci, vol.38, pp.233-242, 2013.

S. Jiang, Y. Li, X. Zhang, G. Bu, H. Xu et al., Trafficking regulation of proteins in Alzheimer's disease, Mol Neurodegener, vol.9, p.6, 2014.

S. Jimenez, M. Torres, M. Vizuete, R. Sanchez-varo, E. Sanchez-mejias et al., Age-dependent accumulation of soluble amyloid beta (A?) oligomers reverses the neuroprotective effect of soluble amyloid precursor protein-? (sAPP?) by modulating phosphatidylinositol 3-kinase (PI3K)/Akt-GSK-3? pathway in Alzheimer mouse model, J Biol Chem, vol.286, pp.18414-18425, 2011.

M. John, T. Ikuta, and J. Ferbinteanu, Graph analysis of structural brain networks in Alzheimer's disease: beyond small world properties, Brain Struct Funct, pp.1-20, 2016.

A. Johnson and J. M. Olefsky, The origins and drivers of insulin resistance, Cell, vol.152, pp.673-684, 2013.

K. A. Johnson, N. C. Fox, R. A. Sperling, and W. E. Klunk, Brain Imaging in Alzheimer Disease. Cold Spring Harb Perspect Med, vol.2, pp.6213-006213, 2012.

C. Julien, C. Tremblay, A. Phivilay, L. Berthiaume, V. Emond et al., High-fat diet aggravates amyloidbeta and tau pathologies in the 3xTg-AD mouse model, Neurobiol Aging, vol.31, pp.1516-1531, 2010.

S. Jurgensen, L. L. Antonio, G. Mussi, J. Brito-moreira, T. R. Bomfim et al., Activation of D1/D5 dopamine receptors protects neurons from synapse dysfunction induced by amyloid oligomers, J Biol Chem, vol.286, pp.3270-3276, 2011.

M. M. Kaczmarczyk, A. S. Machaj, G. S. Chiu, M. A. Lawson, S. J. Gainey et al., Methylphenidate prevents high-fat diet (HFD)-induced learning/memory impairment in juvenile mice, Psychoneuroendocrinology, vol.38, pp.1553-1564, 2013.

J. J. Kulstad, P. S. Green, D. G. Cook, G. S. Watson, M. Reger et al., Differential modulation of plasma beta-amyloid by insulin in patients with Alzheimer disease, Neurology, vol.66, pp.1506-1510, 2006.

S. Kumar-singh, I. Dewachter, D. Moechars, U. Lübke, C. De-jonghe et al., Behavioral disturbances without amyloid deposits in mice overexpressing human amyloid precursor protein with Flemish (A692G) or Dutch (E693Q) mutation, Neurobiol Dis, vol.7, pp.9-22, 2000.

Y. Kwak, C. L. Brannen, T. Qu, H. M. Kim, X. Dong et al., Amyloid precursor protein regulates differentiation of human neural stem cells, Stem Cells Dev, vol.15, pp.381-389, 2006.

F. M. Laferla, K. N. Green, and S. Oddo, Intracellular amyloid-? in Alzheimer's disease, Nat Rev Neurosci, vol.8, pp.499-509, 2007.

H. Lannert and S. Hoyer, Intracerebroventricular administration of streptozotocin causes long-term diminutions in learning and memory abilities and in cerebral energy metabolism in adult rats, Behav Neurosci, vol.112, pp.1199-1208, 1998.

L. Lannfelt, H. Basun, L. O. Wahlund, B. A. Rowe, and S. L. Wagner, Decreased alpha-secretase-cleaved amyloid precursor protein as a diagnostic marker for Alzheimer's disease, Nat Med, vol.1, pp.829-832, 1995.

T. A. Lanz, D. B. Carter, and K. M. Merchant, Dendritic spine loss in the hippocampus of young PDAPP and Tg2576 mice and its prevention by the ApoE2 genotype, Neurobiol Dis, vol.13, pp.246-253, 2003.

M. Laplante and D. M. Sabatini, MTOR signaling in growth control and disease, Cell, vol.149, pp.274-293, 2012.

M. Lappas, GSK3? is increased in adipose tissue and skeletal muscle from women with gestational diabetes where it regulates the inflammatory response, PLoS One, vol.9, pp.1-24, 2014.

C. K. Lardinois and G. H. Starich, Polyunsaturated fats enhance peripheral glucose utilization in rats, J Am Coll Nutr, vol.10, pp.340-345, 1991.

J. Larson, G. Lynch, D. Games, and P. Seubert, Alterations in synaptic transmission and long-term potentiation in hippocampal slices from young and aged PDAPP mice, Brain Res, vol.840, pp.23-35, 1999.

M. Larson, M. A. Sherman, F. Amar, M. Nuvolone, J. A. Schneider et al., The complex PrP(c)-Fyn couples human oligomeric A? with pathological tau changes in Alzheimer's disease, J Neurosci, vol.32, pp.16857-71, 2012.

M. E. Larson and S. E. Lesne, Soluble Abeta oligomer production and toxicity, J Neurochem, vol.120, pp.125-139, 2012.

H. Lassmann, C. Bancher, H. Breitschopf, J. Wegiel, M. Bobinski et al., Cell death in Alzheimer's disease evaluated by DNA fragmentation in situ, Acta Neuropathol, vol.89, pp.35-41, 1995.

L. J. Launer, K. Andersen, M. E. Dewey, L. Letenneur, A. Ott et al., Rates and risk factors for dementia and Alzheimer's disease: results from EURODEM pooled analyses. EURODEM Incidence Research Group and Work Groups, European Studies of Dementia. Neurology, vol.52, pp.78-84, 1999.

D. Laurin, R. Verreault, J. Lindsay, K. Macpherson, and K. Rockwood, Physical activity and risk of cognitive impairment and dementia in elderly persons, Arch Neurol, vol.58, pp.498-504, 2001.

G. Laviola, A. J. Hannan, S. Macrì, M. Solinas, and M. Jaber, Neurobiology of Disease Effects of enriched environment on animal models of neurodegenerative diseases and psychiatric disorders, vol.31, pp.159-168, 2008.

O. Lazarov, J. Robinson, Y. Tang, I. S. Hairston, Z. Korade-mirnics et al., Environmental enrichment reduces Abeta levels and amyloid deposition in transgenic mice, Cell, vol.120, pp.701-713, 2005.

R. Lazarus, R. Prettyman, and G. Cherryman, White matter lesions on magnetic resonance imaging and their relationship with vascular risk factors in memory clinic attenders, Int J Ger, vol.20, pp.274-279, 2005.

J. L. Leahy, Pathogenesis of Type 2 Diabetes Mellitus, Arch Med Res, vol.36, pp.197-209, 2005.

M. Lehmann, S. J. Crutch, G. R. Ridgway, B. H. Ridha, J. Barnes et al., Cortical thickness and voxel-based morphometry in posterior cortical atrophy and typical Alzheimer's disease, Neurobiol Aging, vol.32, pp.1466-1476, 2011.

M. A. Leissring, W. Farris, A. Y. Chang, D. M. Walsh, X. Wu et al., Enhanced proteolysis of ?amyloid in APP transgenic mice prevents plaque formation, secondary pathology, and premature death, Neuron, vol.40, pp.1087-1093, 2003.

M. A. Leissring, W. Farris, X. Wu, D. C. Christodoulou, M. C. Haigis et al., Alternative translation initiation generates a novel isoform of insulin-degrading enzyme targeted to mitochondria, Biochem J, vol.383, pp.439-446, 2004.

C. A. Lemere and E. Masliah, Can Alzheimer disease be prevented by amyloid-beta immunotherapy?, Nat Rev Neurol, vol.6, pp.108-119, 2010.

D. Lenzi, L. Serra, R. Perri, P. Pantano, G. L. Lenzi et al., Single domain amnestic MCI: a multiple cognitive domains fMRI investigation, Neurobiol Aging, vol.32, pp.1542-1557, 2011.

M. Leong, A. C. Maiyar, B. Kim, B. Keeffe, and G. L. Firestone, Expression of the Serum-and Glucocorticoidinducible protein kinase, Sgk, is a cell survival response to multiple types of environmental stress stimuli in mammary epithelial cells, J Biol Chem, vol.278, pp.5871-5882, 2003.

S. Lesné, M. T. Koh, L. Kotilinek, R. Kayed, C. G. Glabe et al., A specific amyloid-? protein assembly in the brain impairs memory, Nature, vol.440, pp.352-357, 2006.

N. Lester-coll, E. J. Rivera, S. J. Soscia, K. Doiron, J. R. Wands et al., Intracerebral streptozotocin model of type 3 diabetes: relevance to sporadic Alzheimer's disease, J Alzheimers Dis, vol.9, pp.13-33, 2006.

O. Levi, A. L. Jongen-relo, J. Feldon, A. D. Roses, and D. M. Michaelson, ApoE4 impairs hippocampal plasticity isoformspecifically and blocks the environmental stimulation of synaptogenesis and memory, Neurobiol Dis, vol.13, pp.273-282, 2003.

B. E. Levin and A. A. Dunn-meynell, Reduced central leptin sensitivity in rats with diet-induced obesity, Am J Physiol Regul Integr Comp Physiol, vol.283, pp.941-949, 2002.

H. Levine, Soluble multimeric Alzheimer beta(1-40) pre-amyloid complexes in dilute solution, Neurobiol Aging, vol.16, pp.755-764, 1995.

Y. Levites, P. Das, R. W. Price, M. J. Rochette, L. A. Kostura et al., Anti-A?42-and anti-A?40-specific mAbs attenuate amyloid deposition in an Alzheimer disease mouse model, J Clin Invest, vol.116, pp.193-201, 2005.

. Levy-lahad-ae, Candidate gene for the chromosome 1 familial Alzheimer's Disease locus, Science, vol.269, pp.973-977, 1995.

E. Levy, M. D. Carman, I. J. Fernandezmadrid, M. D. Power, I. Lieberburg et al., Mutation of the Alzheimers-Disease amyloid gene in hereditary cerebral-hemorrhage, Dutch Type, Science, vol.248, pp.1124-1126, 1990.

N. Li, Loss of acinar cell IKK ? triggers spontaneous pancreatitis in mice, J Clin Invest, vol.123, pp.2231-2243, 2013.

S. Li, S. Hong, N. E. Shepardson, D. M. Walsh, G. M. Shankar et al., Soluble oligomers of amyloid ? protein facilitate hippocampal long-term depression by disrupting neuronal glutamate uptake, Neuron, vol.62, pp.788-801, 2009.

X. Li, D. Song, and S. X. Leng, Link between type 2 diabetes and Alzheimer's disease : from epidemiology to mechanism and treatment, Clin Interv Aging, vol.10, pp.549-560, 2015.

Y. Li, G. I. Tennekoon, M. Birnbaum, M. A. Marchionni, and J. L. Rutkowski, Neuregulin signaling through a PI3K/Akt/Bad pathway in Schwann cell survival, Mol Cell Neurosci, vol.17, pp.761-767, 2001.

X. Lin, G. Koelsch, S. Wu, D. Downs, A. Dashti et al., Human aspartic protease memapsin 2 cleaves the betasecretase site of beta-amyloid precursor protein, Proc Natl Acad Sci U S A, vol.97, pp.1456-1460, 2000.

J. Lindsay, D. Laurin, R. Verreault, R. Hébert, B. Helliwell et al., Risk factors for Alzheimer's disease: a prospective analysis from the Canadian Study of Health and Aging, Am J Epidemiol, vol.156, pp.445-453, 2002.

I. Lista and G. Sorrentino, Biological mechanisms of physical activity in preventing cognitive decline, Cell Mol Neurobiol, vol.30, pp.493-503, 2010.

J. M. Litersky, G. Johnson, R. Jakes, M. Goedert, M. Lee et al., Tau protein is phosphorylated by cyclic AMPdependent protein kinase and calcium/calmodulin-dependent protein kinase II within its microtubule-binding domains at Ser-262 and Ser-356, Biochem J, pp.655-660, 1996.

F. Liu, M. L. Brezniceanu, C. C. Wei, I. Chenier, S. Sachetelli et al., Overexpression of angiotensinogen increases tubular apoptosis in diabetes, J Am Soc Nephrol, vol.19, pp.269-280, 2008.

H. Liu, . Li, G. Zhao, H. Zhang, L. Shi et al., Long-term treadmill exercise inhibits the progression of Alzheimer's diseaselike neuropathology in the hippocampus of APP/PS1 transgenic mice, Behav Brain Res, vol.256, pp.261-272, 2013.

L. Liu, X. Guo, Y. Zhou, and J. Xia, Prevalence of dementia in China, Dement Geriatr Cogn Disord, vol.15, pp.226-230, 2003.

P. Liu, Cell-cycle-regulated activation of Akt kinase by phosphorylation at its carboxyl terminus, Nature, vol.508, pp.541-545, 2014.

Q. Liu, C. Zerbinatti, J. Zhang, H. Hoe, B. Wang et al., Amyloid precursor protein regulates brain apolipoprotein E and cholesterol metabolism through lipoprotein receptor LRP1, Neuron, vol.56, pp.66-78, 2007.

Y. Liu, F. Grundke-iqbal, K. I. Gong, and C. , Deficient brain insulin signalling pathway in Alzheimer's disease and diabetes, J pathol, vol.225, pp.54-62, 2011.

Y. Liu, F. Liu, K. Iqbal, I. Grundke-iqbal, and A. Et, Decreased glucose transporters correlate to abnormal hyperphosphorylation of tau in Alzheimer disease, FEBS Lett, vol.582, pp.359-364, 2008.

Z. Liu, I. Y. Patil, T. Jiang, H. Sancheti, J. P. Walsh et al., High-fat diet induces hepatic insulin resistance and impairment of synaptic plasticity, PLoS One, vol.10, p.128274, 2015.

R. E. Llovera, M. De-tullio, L. G. Alonso, M. A. Leissring, S. B. Kaufman et al., The catalytic domain of insulin-degrading enzyme forms a denaturant-resistant complex with amyloid ? peptide: Implications for Alzheimer disease pathogenesis, J Biol Chem, vol.283, pp.17039-17048, 2008.

Z. Long, M. Zheng, L. Zhao, P. Xie, C. Song et al., Valproic acid attenuates neuronal loss in the brain of APP/PS1 double transgenic Alzheimer's disease mice model, Curr Alzheimer Res, vol.10, pp.261-269, 2013.

A. Lorenzo and B. A. Yankner, Beta-amyloid neurotoxicity requires fibril formation and is inhibited by congo red, Proc Natl Acad Sci, vol.91, pp.12243-12247, 1994.

M. Lövdén, N. C. Bodammer, S. Kühn, J. Kaufmann, H. Schütze et al., Experience-dependent plasticity of white-matter microstructure extends into old age, Neuropsychologia, vol.48, pp.3878-3883, 2010.

F. P. Lu, K. P. Lin, and H. K. Kuo, Diabetes and the risk of multi-system aging phenotypes: A systematic review and metaanalysis, PLoS One, vol.4, p.4144, 2009.

J. A. Luchsinger, M. Tang, S. Shea, and R. Mayeux, Caloric intake and the risk of Alzheimer disease, Arch Neurol, vol.59, pp.1258-1263, 2002.

J. A. Luchsinger and D. R. Gustafson, Adiposity and Alzheimer?s disease, Curr Opin Clin Nutr Metab Care, vol.12, pp.15-21, 2009.

J. A. Luchsinger, M. Tang, S. Shea, and R. Mayeux, Hyperinsulinemia and risk of Alzheimer disease, Neurology, vol.63, pp.1187-1192, 2004.

J. A. Luchsinger, M. X. Tang, Y. Stern, S. Shea, and R. Mayeux, Diabetes mellitus and risk of Alzheimer's disease and dementia with stroke in a multiethnic cohort, Am J Epidemiol, vol.154, pp.635-641, 2001.

L. F. Lue, L. Brachova, W. H. Civin, and J. Rogers, Inflammation, A beta deposition, and neurofibrillary tangle formation as correlates of Alzheimer's disease neurodegeneration, J Neuropathol Exp Neurol, vol.55, pp.1083-1088, 1996.

L. F. Lue, Y. M. Kuo, A. E. Roher, L. Brachova, Y. Shen et al., Soluble amyloid beta peptide concentration as a predictor of synaptic change in Alzheimer's disease, Am J Pathol, vol.155, pp.853-862, 1999.

L. F. Lue and D. G. Walker, Modeling Alzheimer's disease immune therapy mechanisms: Interactions of human postmortem microglia with antibody-opsonized amyloid beta peptide, J Neurosci Res, vol.70, pp.599-610, 2002.

L. F. Lue, D. G. Walker, and J. Rogers, Modeling microglial activation in Alzheimer's disease with human postmortem microglial cultures, Neurobiol Aging, vol.22, pp.945-956, 2001.

S. Lund, A. Flyvbjerg, G. D. Holman, F. S. Larsen, O. Pedersen et al., Comparative effects of IGF-I and insulin on the glucose transporter system in rat muscle, Am J Physiol, vol.267, pp.461-467, 1994.

T. Ma, C. A. Hoeffer, E. Capetillo-zarate, F. Yu, H. Wong et al., Dysregulation of the mTOR pathway mediates impairment of synaptic plasticity in a mouse model of Alzheimer's disease, PLoS One, vol.5, pp.1-10, 2010.

X. Ma, Z. Li, B. Jing, H. Liu, D. Li et al., Identify the atrophy of Alzheimer's Disease, mild cognitive impairment and normal aging using morphometric MRI analysis, Front Aging Neurosci, vol.8, pp.1-10, 2016.

Y. Q. Ma, D. K. Wu, and J. K. Liu, mTOR and tau phosphorylated proteins in the hippocampal tissue of rats with type 2 diabetes and Alzheimer's disease, Mol Med Rep, vol.7, pp.623-627, 2013.

A. J. Mably, W. Liu, J. M. Mc, J. Dodart, F. Bard et al., Anti-A? antibodies incapable of reducing cerebral A? oligomers fail to attenuate spatial referencememory deficits in J20mice, Neurobiol Dis, vol.82, pp.372-384, 2015.

R. B. Maccioni, J. P. Muñoz, and L. Barbeito, The molecular bases of Alzheimer's disease and other neurodegenerative disorders, Arch Med Res, vol.32, pp.367-381, 2001.

R. W. Mackenzie and B. T. Elliott, Akt/PKB activation and insulin signaling: a novel insulin signaling pathway in the treatment of type 2 diabetes, Diabetes Metab Syndr Obes, vol.7, pp.55-64, 2014.

M. Maesako, K. Uemura, M. Kubota, A. Kuzuya, K. Sasaki et al., Environmental enrichment ameliorated high-fat diet-induced A? deposition and memory deficit in APP transgenic mice, Neurobiol Aging, vol.33, pp.1011-1022, 2012.

M. H. Magdesian, M. Carvalho, F. A. Mendes, L. M. Saraiva, M. A. Juliano et al., Amyloid-Binds to the Extracellular Cysteine-rich Domain of Frizzled and Inhibits Wnt/ ?-Catenin Signaling, J Biol Chem, vol.283, pp.9359-9368, 2008.

M. C. Maiuri, E. Zalckvar, A. Kimchi, and G. Kroemer, Self-eating and self-killing: crosstalk between autophagy and apoptosis, Nat Rev Mol Cell Biol, vol.8, pp.741-752, 2007.

A. Mancino, M. Habbeddine, J. E. Luron, L. Bebien, M. Memet et al., ) I kappa B kinase alpha (IKK?) activity is required for functional maturation of dendritic cells and acquired immunity to infection, EMBO J, vol.32, pp.816-828, 2013.

E. M. Mandelkow and E. Mandelkow, Tau in Alzheimer's disease, Trends Cell Biol, vol.8, pp.425-427, 1998.

B. Manning and L. Cantley, AKT/PKB Signalling: Navigating Downstream, Cell, vol.129, pp.1261-1274, 2007.

M. Marchetti and H. Marie, Hippocampal synaptic plasticity in Alzheimer's disease: What have we learned so far from transgenic models?, Rev Neurosci, vol.22, pp.373-402, 2011.

M. W. Marlatt, M. C. Potter, T. A. Bayer, H. Van-praag, and P. J. Lucassen, Prolonged Running, not Fluoxetine Treatment, Increases Neurogenesis, but does not Alter Neuropathology, in the 3xTg Mouse Model of Alzheimer's Disease, Current topics in behavioral neurosciences, pp.313-340, 2013.

M. C. Morris,

A. Denis,

C. C. Tangney and P. ,

J. L. Bienias and S. , Fish consumption and cognitive decline with age in a large community study, Arch Neurol, vol.62, pp.1849-1853, 2005.

R. Martins, G. Lithgow, and W. Link, Long live FOXO: Unraveling the role of FOXO proteins in aging and longevity, Aging Cell, vol.15, pp.196-207, 2016.

E. Masliah, L. A. Hansen, S. Quijada, R. Deteresa, M. Alford et al., Late onset dementia with argyrophilic grains and subcortical tangles or atypical progressive supranuclear palsy, Ann Neurol, vol.29, pp.389-396, 1991.

E. Masliah, M. Mallory, L. Hansen, R. Deteresa, M. Alford et al., Synaptic and neuritic alterations during the progression of Alzheimer's disease, Neurosci Lett, vol.174, pp.67-72, 1994.

E. Masliah, A. Sisk, M. Mallory, and D. Games, Neurofibrillary pathology in transgenic mice overexpressing V717F ?amyloid precursor protein, J Neuropathol Exp Neurol, vol.60, pp.357-368, 2001.

M. P. Mattson, W. Duan, and Z. Guo, Meal size and frequency affect neuronal plasticity and vulnerability to disease: cellular and molecular mechanisms, J Neurochem, vol.84, pp.417-431, 2003.

K. Maurer, S. Volk, and H. Gerbaldo, Auguste D and Alzheimer's disease, Lancet, vol.349, pp.1906-1909, 1997.

M. I. Mccarthy, Genomic medicine at the heart of diabetes management, Diabetologia, vol.58, pp.1725-1729, 2015.

P. L. Mcclean, V. Parthsarathy, E. Faivre, and C. Holscher, The Diabetes Drug Liraglutide Prevents Degenerative Processes in a Mouse Model of Alzheimer's Disease, J Neurosci, vol.31, pp.6587-6594, 2011.

K. Mclellan, A. C. Lerario, and R. C. Burini, Prevention of diabetes: Effects of a lifestyle intervention, InTech, vol.8, pp.163-176, 2011.

M. Medina and F. Wandosell, Deconstructing GSK-3: The fine regulation of its activity, Int J Alzheimers Dis, p.479249, 2011.

G. S. Meneilly and D. M. Tessier, Diabetes, dementia and hypoglycemia, Can J Diabetes, vol.40, pp.73-76, 2016.

E. M. Mercken, B. A. Carboneau, S. M. Krzysik-walker, D. Cabo, and R. , Of mice and men: The benefits of caloric restriction, exercise, and mimetics, Ageing Res Rev, vol.11, pp.390-398, 2012.

H. Meziane, J. C. Dodart, C. Mathis, S. Little, J. Clemens et al., Memory-enhancing effects of secreted forms of the beta-amyloid precursor protein in normal and amnestic mice, Proc Natl Acad Sci U S A, vol.95, pp.12683-12688, 1998.

L. E. Middleton, D. E. Barnes, L. Y. Lui, and K. Yaffe, Physical activity over the life course and its association with cognitive performance and impairment in old age, J Am Geriatr Soc, vol.58, pp.1322-1326, 2010.

J. G. Mielke, K. Nicolitch, V. Avellaneda, K. Earlam, T. Ahuja et al., Longitudinal study of the effects of a high-fat diet on glucose regulation, hippocampal function, and cerebral insulin sensitivity in C57BL/6 mice, Behav Brain Res, vol.175, pp.374-382, 2006.

J. G. Mielke, C. Taghibiglou, L. Liu, Y. Zhang, Z. Jia et al., A biochemical and functional characterization of diet-induced brain insulin resistance, J Neurochem, vol.93, pp.1568-1578, 2005.

J. Miklossy, H. Qing, A. Radenovic, A. Kis, B. Vileno et al., Neurobiol Aging, vol.31, pp.1503-1515, 2010.

B. C. Miller, E. A. Eckman, K. Sambamurti, N. Dobbs, K. M. Chow et al., Amyloid-beta peptide levels in brain are inversely correlated with insulysin activity levels in vivo, Proc Natl Acad Sci U S A, vol.100, pp.6221-6226, 2003.

S. L. Miller, K. Celone, K. Depeau, E. Diamond, B. C. Dickerson et al., Age-related memory impairment associated with loss of parietal deactivation but preserved hippocampal activation, Proc Natl Acad Sci U S A, vol.105, pp.2181-2186, 2008.

E. A. Minina, V. Sanchez-vera, P. N. Moschou, M. F. Suarez, E. Sundberg et al., Autophagy mediates caloric restriction-induced lifespan extension in Arabidopsis, Aging Cell, vol.12, pp.327-329, 2013.

S. Minoshima, B. Giordani, S. Berent, K. A. Frey, N. L. Foster et al., Metabolic reduction in the posterior cingulate cortex in very early Alzheimer's disease, Ann Neurol, vol.42, pp.85-94, 1997.

M. A. Mintun, G. N. Larossa, Y. I. Sheline, C. S. Dence, S. Y. Lee et al., 11C]PIB in a nondemented population: potential antecedent marker of Alzheimer disease, Neurology, vol.67, pp.446-452, 2006.

S. Mirochnic, S. Wolf, M. Staufenbiel, and G. Kempermann, Age effects on the regulation of adult hippocampal neurogenesis by physical activity and environmental enrichment in the APP23 mouse model of Alzheimer disease, Hippocampus, vol.19, pp.1008-1018, 2009.

J. C. Mitchell, B. B. Ariff, D. M. Yates, K. Lau, M. S. Perkinton et al., X11beta rescues memory and long-term potentiation deficits in Alzheimer's disease APPswe Tg2576 mice, Hum Mol Genet, vol.18, pp.4492-4500, 2009.

K. Mittal and D. P. Katare, Shared links between type 2 diabetes mellitus and Alzheimer's disease: A review, Diabetes Metab Syndr Clin Res Rev, vol.10, pp.1-6, 2016.

D. Moechars, I. Dewachter, D. Reversé, V. Baekelandt, A. Naidu et al., Early Phenotypic Changes in Transgenic Mice That Overexpress Different Mutants of Amyloid Precursor Protein in Brain Early Phenotypic Changes in Transgenic Mice That Overexpress Different Mutant, vol.274, pp.6483-6492, 1999.

A. M. Moloney, R. J. Griffin, S. Timmons, R. O'connor, R. Ravid et al., Defects in IGF-1 receptor, insulin receptor and IRS-1/2 in Alzheimer's disease indicate possible resistance to IGF-1 and insulin signalling, Neurobiol Aging, vol.31, pp.224-243, 2010.

A. Monsonego, J. Imitola, S. Petrovic, V. Zota, A. Nemirovsky et al., A betainduced meningoencephalitis is IFN-gamma-dependent and is associated with T cell-dependent clearance of A beta in a mouse model of Alzheimer's disease, Proc Natl Acad Sci U S A, vol.103, pp.5048-5053, 2006.

A. D. Mooradian, H. C. Chung, and G. N. Shah, GLUT-1 expression in the cerebra of patients with Alzheimer's disease, Neurobiol Aging, vol.18, pp.469-474, 1997.

K. M. Moore, R. E. Girens, S. K. Larson, M. R. Jones, J. L. Restivo et al., A spectrum of exercise training reduces soluble A? in a dose-dependent manner in a mouse model of Alzheimer's disease, Neurobiol Dis, vol.85, pp.218-224, 2016.

F. Mora, G. Segovia, and A. Arco, Aging , plasticity and environmental enrichment : Structural changes and neurotransmitter dynamics in several areas of the brain, Brain Res Rev, vol.5, pp.78-88, 2007.

J. C. Moraes, A. Coope, J. Morari, D. E. Cintra, E. A. Roman et al., High-fat diet induces apoptosis of hypothalamic neurons, PLoS One, vol.4, p.5045, 2009.

S. Morais-cardoso, R. H. Swerdlow, and C. R. Oliveira, Induction of cytochrome c-mediated apoptosis by amyloid ? 25-35 requires functional mitochondria, Brain Res, vol.931, pp.117-125, 2002.

D. Morgan, D. M. Diamond, P. E. Gottschall, K. E. Ugen, C. Dickey et al., A? peptide vaccination prevents memory loss in an animal model of Alzheimer's disease, Nature, vol.408, pp.982-985, 2000.

R. G. Morris, P. Garrud, J. N. Rawlins, and J. O'keefe, Place navigation impaired in rats with hippocampal lesions, Nature, vol.297, pp.681-683, 1982.

G. E. Mortimore and A. R. Pösö, Intracellular protein catabolism and its control during nutrient deprivation and supply, Annu Rev Nutr, vol.7, pp.539-564, 1987.

G. E. Mortimore, A. R. Poso, and B. R. Lardeux, Mechanism and regulation of protein degradation in liver, Diabetes/Metab Rev, vol.5, pp.49-70, 1989.

K. Motyl and L. R. Mccabe, Streptozotocin , Type I Diabetes Severity and Bone, Biol Proced inline, vol.11, pp.296-315, 2009.

P. R. Mouton, M. E. Chachich, C. Quigley, E. Spangler, and D. K. Ingram, Caloric restriction attenuates amyloid deposition in middle-aged dtg APP/PS1 mice, Neurosci Lett, vol.464, pp.184-187, 2009.

L. Mucke, E. Masliah, W. B. Johnson, M. D. Ruppe, M. Alford et al., Synaptotrophic effects of human amyloid beta protein precursors in the cortex of transgenic mice, Brain Res, vol.666, pp.151-167, 1994.

L. Mucke, E. Masliah, G. Q. Yu, M. Mallory, E. M. Rockenstein et al., High-level neuronal expression of abeta 1-42 in wild-type human amyloid protein precursor transgenic mice: synaptotoxicity without plaque formation, J Neurosci, vol.20, pp.4050-4058, 2000.

M. Mullan, H. Houlden, M. Windelspecht, L. Fidani, C. Lombardi et al., A locus for familial early-onset Alzheimer's disease on the long arm of chromosome 14, proximal to the alpha 1-antichymotrypsin gene, Nat Genet, vol.2, pp.340-342, 1992.

K. Mullane and M. Williams, Alzheimer's therapeutics: Continued clinical failures question the validity of the amyloid hypothesis -But what lies beyond?, Biochem Pharmacol, vol.85, pp.289-305, 2013.

T. Müller, H. E. Meyer, R. Egensperger, and K. Marcus, The amyloid precursor protein intracellular domain (AICD) as modulator of gene expression, apoptosis, and cytoskeletal dynamics-relevance for Alzheimer's disease, Prog Neurobiol, vol.85, pp.393-406, 2008.

E. E. Mulvihill, E. M. Allister, B. G. Sutherland, D. E. Telford, C. G. Sawyez et al., Receptor -null mice with diet-induced insulin resistance, Diabetes, vol.58, pp.2198-2210, 2009.

T. Nakamura, T. Terajima, T. Ogata, K. Ueno, N. Hashimoto et al., Establishment and pathophysiological characterization of type 2 diabetic mouse model produced by streptozotocin and nicotinamide, Biol Pharm Bull, vol.29, pp.1167-1174, 2006.

D. M. Nathan, International expert committee report on the role of the A1C assay in the diagnosis of diabetes, Diabetes Care, vol.32, pp.1327-1334, 2009.

T. J. Nelson and D. L. Alkon, Insulin and cholesterol pathways in neuronal function, memory and neurodegeneration, Biochem Soc Trans, vol.33, pp.1033-1036, 2005.

T. Ngandu, V. Strauss, E. Helkala, E. L. Winblad, B. Nissinen et al., Education and dementia: What lies behind the association, Neurology, vol.69, pp.1442-1450, 2007.

C. Ngarmukos, E. L. Baur, and A. K. Kumagai, Co-localization of GLUT1 and GLUT4 in the blood-brain barrier of the rat ventromedial hypothalamus, Brain Res, vol.900, pp.1-8, 2001.

V. Nicolia, M. Lucarelli, and A. Fuso, Environment, epigenetics and neurodegeneration: Focus on nutrition in Alzheimer's disease, Exp Gerontol, vol.68, pp.8-12, 2015.

J. Nicoll, D. Wilkinson, C. Holmes, P. Steart, H. Markham et al., Neuropathology of human Alzheimer disease after immunization with amyloid-beta peptide: a case report, Nat Med, vol.9, pp.448-452, 2003.

D. Nijhawan, N. Honarpour, and X. Wang, Apoptosis in neural development and disease, Proteins, vol.37, pp.73-87, 2000.

J. Nithianantharajah and A. J. Hannan, Enriched environments, experience-dependent plasticity and disorders of the nervous system, Nat Rev Neurosci, vol.7, pp.697-709, 2006.

C. Nordstedt, G. L. Caporaso, J. Thyberg, S. E. Gandy, and P. Greengard, Identification of the Alzheimer beta/A4 amyloid precursor protein in clathrin-coated vesicles purified from PC12 cells, J Biol Chem, vol.268, pp.608-612, 1993.

C. Ntsapi and B. Loos, Caloric restriction and the precision-control of autophagy: A strategy for delaying neurodegenerative disease progression, Exp Gerontol, vol.83, pp.97-111, 2016.

P. D. O'brien, S. A. Sakowski, and E. L. Feldman, Mouse models of diabetic neuropathy, ILAR, vol.54, pp.259-272, 2014.

J. N. O'neil, P. R. Mouton, Y. Tizabi, M. A. Ottinger, D. L. Lei et al., Catecholaminergic neuronal loss in locus coeruleus of aged female dtg APP/PS1 mice, J Chem Neuroanat, vol.34, pp.102-107, 2007.

C. O'neill, A. P. Kiely, M. F. Coakley, S. Manning, and C. M. Long-smith, Insulin and IGF-1 signalling: longevity, protein homoeostasis and Alzheimer's disease, Biochem Soc Trans, vol.40, pp.721-727, 2012.

S. Oddo, A. Caccamo, J. D. Shepherd, M. P. Murphy, T. E. Golde et al., Triple-transgenic model of Alzheimer's Disease with plaques and tangles: Intracellular A? and synaptic dysfunction, Neuron, vol.39, pp.409-421, 2003.

A. Ogunniyi, K. A. Lane, O. Baiyewu, S. Gao, O. Gureje et al., Hypertension and incident dementia in community-dwelling elderly Yoruba Nigerians, Acta Neurol Scand, vol.124, pp.396-402, 2011.

M. Ohno, L. Chang, W. Tseng, H. Oakley, M. Citron et al., Temporal memory deficits in Alzheimer's mouse models: Rescue by genetic deletion of BACE1, Eur J Neurosci, vol.23, pp.251-260, 2006.

J. T. Opferman and S. J. Korsmeyer, Apoptosis in the development and maintenance of the immune system, Nat Immunol, vol.4, pp.410-415, 2003.

J. M. Orgogozo, S. Gilman, J. F. Dartigues, B. Laurent, M. Puel et al., Subacute meningoencephalitis in a subset of patients with AD after Abeta42 immunization, Neurology, vol.61, pp.46-54, 2003.

D. M. Osborne, K. E. O'leary, D. P. Fitzgerald, A. J. George, M. M. Vidal et al., Context-dependent memory following recurrent hypoglycaemia in non-diabetic rats is mediated via glucocorticoid signalling in the dorsal hippocampus, pp.1-10, 2016.

J. J. Palop and L. Mucke, Amyloid-beta-induced neuronal dysfunction in Alzheimer's disease: from synapses toward neural networks, Nat Neurosci, vol.13, pp.812-818, 2010.

N. Pamidi and S. Nayak, Effect of environmental enrichment exposure on neuronal morphology of streptozotocininduced diabetic and stressed rat hippocampus, Biomed J, vol.37, p.225, 2014.

F. Panza, V. Frisardi, B. P. Imbimbo, D. Seripa, V. Solfrizzi et al., Monoclonal antibodies against ?-amyloid (A?) for the treatment of Alzheimer's disease: the A? target at a crossroads, Expert Opin Biol Ther, vol.11, pp.679-686, 2011.

M. Pap and G. M. Cooper, Role of Glycogen Synthase Kinase-3 in the Akt Cell Survival Pathway, J Biol Chem, vol.273, pp.19929-19932, 1998.

M. S. Parihar and G. J. Brewer, Amyloid Beta as a Modulator of Synaptic Plasticity, J Alzheimers Dis, vol.22, issue.3, pp.741-763, 2011.

C. Park, Cognitive effects of insulin in the central nervous system, Neurosci Biobehav Rev, vol.25, pp.311-323, 2001.

S. Parvathy, I. Hussain, E. H. Karran, A. J. Turner, and N. M. Hooper, Cleavage of Alzheimer's amyloid precursor protein by alpha-secretase occurs at the surface of neuronal cells, Biochemistry, vol.38, pp.9728-9734, 1999.

S. Patel and D. Santani, Role of NFkB in the pathogenesis of diabetes and its associated complications, Pharmacol Reports, vol.61, pp.595-603, 2009.

N. Patel, M. N. Gordon, K. E. Connor, R. A. Good, R. W. Engelman et al., Caloric restriction attenuates A?-deposition in Alzheimer transgenic models, Neurobiol Aging, vol.26, pp.995-1000, 2005.

D. J. Pedersen, A. Guilherme, L. V. Danai, L. Heyda, A. Matevossian et al., A major role of insulin in promoting obesity-associated adipose tissue inflammation, Mol Metab, vol.4, pp.507-518, 2015.

J. Pei, E. Braak, H. Braak, I. Grundke-iqbal, K. Iqbal et al., Distribution of active glycogen synthase kinase 3? (GSK-3?) in brains staged for Alzheimer disease neurofibrillary changes, J Neuropathol Exp Neurol, vol.58, pp.1010-1019, 1999.

R. Peila, B. L. Rodriguez, and L. J. Launer, Type 2 Diabetes, APOE Gene, and the risk for dementia and related pathologies, Diabetes, vol.51, pp.1256-1262, 2002.

L. Pellerin, Brain energetics (thought needs food), Curr Opin Clin Nutr Metab Care, vol.11, pp.701-705, 2008.

R. C. Petersen, Mild cognitive impairment as a diagnostic entity, J Intern Med, vol.256, pp.183-194, 2004.

M. D. Peterson, P. M. Gordon, and E. A. Hurvitz, Chronic disease risk among adults with cerebral palsy: The role of premature sarcopoenia, obesity and sedentary behaviour, Obes Rev, vol.14, pp.171-182, 2013.

D. Petrov, I. Pedrós, G. Artiach, F. X. Sureda, E. Barroso et al., High-fat diet-induced deregulation of hippocampal insulin signaling and mitochondrial homeostasis deficiences contribute to Alzheimer disease pathology in rodents, Biochim Biophys Acta -Mol Basis Dis, vol.1852, pp.1687-1699, 2015.

C. J. Phiel, C. Wilson, V. Lee, and P. S. Klein, GSK-3alpha regulates production of Alzheimer's disease amyloidbeta peptides, Nature, vol.423, pp.435-439, 2003.

F. Piazza, G. Pinto, G. Trott, S. Marcuzzo, R. Gomez et al., Enriched environment prevents memory deficits in type 1 diabetic rats, Behav Brain Res, vol.217, pp.16-20, 2011.

F. Pickford, E. Masliah, M. Britschgi, K. Lucin, R. Narasimhan et al., The autophagy-related protein beclin 1 showes reduced expression in eary Alzheimer disease and regulates amyloid beta accumulation in mice, J Clin Invest, vol.118, pp.2190-2199, 2008.

S. Pietropaolo, J. Feldon, and B. K. Yee, Age-dependent phenotypic characteristics of a triple transgenic mouse model of Alzheimer disease, Behav Neurosci, vol.122, pp.733-747, 2008.

C. J. Pike, M. J. Overman, and C. W. Cotman, Amino-terminal deletions enhance aggregation of beta-amyloid peptides in vitro, J Biol Chem, vol.270, pp.23895-23898, 1995.

H. Pintana, N. Apaijai, W. Pratchayasakul, N. Chattipakorn, and S. C. Chattipakorn, Effects of metformin on learning and memory behaviors and brain mitochondrial functions in high fat diet induced insulin resistant rats, Life Sci, vol.91, pp.409-414, 2012.

F. Piras, A. Cherubini, C. Caltagirone, and G. Spalletta, Education mediates microstructural changes in bilateral hippocampus, Hum Brain Mapp, vol.32, pp.282-289, 2011.

B. L. Plassman, R. J. Havlik, D. C. Steffens, M. J. Helms, T. N. Newman et al., Documented head injury in early adulthood and risk of Alzheimer's disease and other dementias, Neurology, vol.55, pp.1158-1166, 2000.

L. J. Podewils, E. Guallar, L. H. Kuller, L. P. Fried, O. L. Lopez et al., Physical activity, APOE genotype, and dementia risk: findings from the Cardiovascular Health Cognition Study, Am J Epidemiol, vol.161, pp.639-651, 2005.

P. N. Pompl, S. Yemul, Z. Xiang, L. Ho, V. Haroutunian et al., Caspase gene expression in the brain as a function of the clinical progression of Alzheimer disease, Arch Neurol, vol.60, pp.369-376, 2003.

J. Pozueta, R. Lefort, and M. L. Shelanski, Synaptic changes in Alzheimer's disease and its models, Neuroscience, vol.251, pp.51-65, 2013.

S. Prasad, R. K. Sajja, P. Naik, and L. Cucullo, Diabetes Mellitus and Blood-Brain Barrier Dysfunction: An Overview, J Pharmacovigil, vol.2, pp.125-150, 2014.

E. Prats, M. Monfar, J. Castellà, R. Iglesias, and M. Alemany, Energy intake of rats fed a cafeteria diet, Physiol Behav, vol.45, pp.263-272, 1989.

J. L. Price, Neuropathology of nondemented aging: presumptive evidence for preclinical Alzheimer disease, Neurobiol Aging, vol.30, pp.1026-1036, 2009.

M. Prince, M. Karagiannidou, M. Prince, M. Karagiannidou, A. Comas-herrera et al., Alzheimer Report 2016 Improving healthcare for people living with dementia, 2016.

L. A. Profenno, A. P. Porsteinsson, and S. V. Faraone, Meta-Analysis of Alzheimer's Disease Risk with Obesity, Diabetes, and Related Disorders, Biol Psychiatry, vol.67, pp.505-512, 2010.

T. R. Prohaska and K. E. Peters, Physical activity and cognitive functioning: translating research to practice with a public health approach, Alzheimers Dement, vol.3, pp.58-64, 2007.

Z. Punthakee, M. E. Miller, L. J. Launer, J. D. Williamson, R. M. Lazar et al., Poor Cognitive Function and Risk of Severe Hypoglycemia in Type 2 Diabetes, Diabetes Care, vol.35, pp.1-7, 2012.

D. Puzzo, L. Privitera, E. Leznik, M. Fà, A. Staniszewski et al., Picomolar amyloid-beta positively modulates synaptic plasticity and memory in hippocampus, J Neurosci, vol.28, pp.14537-14545, 2008.

G. Qiu, E. L. Spangler, R. Wan, M. Miller, M. P. Mattson et al., Neuroprotection provided by dietary restriction in rats is further enhanced by reducing glucocortocoids, Neurobiol Aging, vol.33, pp.2398-2410, 2012.

M. Radenkovi?, M. Stojanovi?, and M. Prostran, Experimental diabetes induced by alloxan and streptozotocin: The current state of the art, J Pharmacol Toxicol Methods, vol.78, pp.13-31, 2016.

A. Rahigude, P. Bhutada, S. Kaulaskar, M. Aswar, and K. Otari, Participation of antioxidant and cholinergic system in protective effect of naringenin against type-2 diabetes-induced memory dysfunction in rats, Neuroscience, vol.226, pp.62-72, 2012.

M. E. Raichle, A. M. Macleod, A. Z. Snyder, W. J. Powers, D. A. Gusnard et al., A default mode of brain function, Proc Natl Acad Sci, vol.98, pp.676-682, 2001.

J. J. Ramos-rodriguez, S. Molina-gil, R. Rey-brea, E. Berrocoso, and M. Garcia-alloza, Specific serotonergic denervation affects tau pathology and cognition without altering senile plaques deposition in APP/PS1 mice, PLoS One, vol.8, p.79947, 2013.

L. P. Reagan, Diabetes as a chronic metabolic stressor: Causes, consequences and clinical complications, Exp Neurol, vol.233, pp.68-78, 2012.

V. A. Redila and B. R. Christie, Exercise-induced changes in dendritic structure and complexity in the adult hippocampal dentate gyrus, Neuroscience, vol.137, pp.1299-1307, 2006.

J. C. Reed, Mechanisms of Bcl-2 family protein function and dysfunction in health and disease, Behring Inst Mitt, vol.97, pp.72-100, 1996.

M. J. Reed, K. Meszaros, L. J. Entes, M. D. Claypool, J. G. Pinkett et al., A new rat model of type 2 diabetes: The fat-fed, streptozotocin-treated rat, Metabolism, vol.49, pp.1390-1394, 2000.

M. A. Reger, G. S. Watson, W. H. Frey, L. D. Baker, B. Cholerton et al., Effects of intranasal insulin on cognition in memory-impaired older adults: modulation by APOE genotype, Neurobiol Aging, vol.27, pp.451-458, 2006.

M. A. Reger, G. S. Watson, P. S. Green, C. W. Wilkinson, L. D. Baker et al., Intranasal insulin improves cognition and modulates beta-amyloid in early AD, Neurology, vol.70, pp.440-448, 2008.

. Reinhold, H. Schmidt, J. D. Curb, K. Masaki, L. R. White et al., Early inflammation and dementia: A 25-year follow-up of the Honolulu-Asia Aging Study, Ann Neurol, vol.52, pp.168-174, 2002.

B. Reisberg, E. H. Franssen, S. M. Hasan, I. Monteiro, I. Boksay et al., Retrogenesis: clinical, physiologic, and pathologic mechanisms in brain aging, Alzheimer's and other dementing processes, Eur Arch Psychiatry Clin Neurosci, vol.249, pp.28-36, 1999.

R. Resende, P. I. Moreira, T. Proença, A. Deshpande, J. Busciglio et al., Brain oxidative stress in a triple-transgenic mouse model of Alzheimer disease, Free Radic Biol Med, vol.44, pp.2051-2057, 2008.

T. Y. Reuter, Diet-induced models for obesity and type 2 diabetes, Drug Discov Today Dis Model, vol.4, pp.3-8, 2007.

G. Riccardi, R. Giacco, and A. Rivellese, Dietary fat, insulin sensitivity and the metabolic syndrome, Clin Nutr, vol.23, pp.447-456, 2004.

K. P. Riley, D. A. Snowdon, M. F. Desrosiers, and W. R. Markesbery, Early life linguistic ability, late life cognitive function, and neuropathology: findings from the Nun Study, Neurobiol Aging, vol.26, pp.341-347, 2005.

W. Rizza, N. Veronese, and L. Fontana, What are the roles of calorie restriction and diet quality in promoting healthy longevity?, Ageing Res Rev, vol.13, pp.38-45, 2014.

J. M. Roch, E. Masliah, A. C. Roch-levecq, M. P. Sundsmo, D. A. Otero et al., Increase of synaptic density and memory retention by a peptide representing the trophic domain of the amyloid beta/A4 protein precursor, Proc Natl Acad Sci U S A, vol.91, pp.7450-7454, 1994.

A. B. Rocher, F. Chapon, X. Blaizot, J. Baron, and C. Chavoix, Resting-state brain glucose utilization as measured by PET is directly related to regional synaptophysin levels: a study in baboons, Neuroimage, vol.20, pp.1894-1898, 2003.

K. Rockwood and L. Middleton, Physical activity and the maintenance of cognitive function, Alzheimer's Dement, vol.3, pp.38-44, 2007.

A. Rodríguez, V. Catalán, J. Gómez-ambrosi, S. García-navarro, F. Rotellar et al., Insulin-and leptin-mediated control of aquaglyceroporins in human adipocytes and hepatocytes is mediated via the PI3K/Akt/mTOR signaling cascade, J Clin Endocrinol Metab, vol.96, pp.586-597, 2011.

E. I. Rogaev, R. Sherrington, G. Rogaeva-e-a,-levesque, M. Ikeda, Y. Liang et al., Familial Alzheimer's disease in kindreds with missense mutations in a gene on chromosome 1 related to the Alzheimer's disease type 3 gene, Nature, vol.376, pp.775-778, 1995.

H. A. Rohan-de-silva, J. A. Wickenden, C. Jen, L. S. Wilkinson, S. L. Patel et al., Cell-specific expression of betaamyloid precursor protein isoform mRNAs and proteins in neurons and astrocytes, Brain Res Mol Brain Res, vol.47, pp.147-156, 1997.

T. T. Rohn, R. A. Rissman, M. C. Davis, Y. E. Kim, C. W. Cotman et al., Caspase-9 activation and caspase cleavage of tau in the Alzheimer's disease brain, Neurobiol Dis, vol.11, pp.341-354, 2002.

J. S. Roriz-filho, T. M. Sá-roriz, I. Rosset, A. L. Camozzato, A. C. Santos et al., Pre)diabetes, brain aging, and cognition, Biochim Biophys Acta -Mol Basis Dis, vol.1792, pp.432-443, 2009.
URL : https://hal.archives-ouvertes.fr/hal-00562889

N. Rösler, I. Wichart, and K. A. Jellinger, Intra vitam lumbar and post mortem ventricular cerebrospinal fluid immunoreactive interleukin-6 in Alzheimer's disease patients, Acta Neurol Scand, vol.103, pp.126-130, 2001.

A. A. Rossini, A. A. Like, W. L. Chick, M. C. Appel, and G. F. Cahill, Studies of streptozotocin-induced insulitis and diabetes, Proc Natl Acad Sci, vol.74, pp.2485-2489, 1977.

N. J. Rothwell and M. J. Stock, The cafeteria diet as a tool for studies of thermogenesis, J Nutr, vol.118, pp.925-928, 1988.

S. Rovio, I. Kareholt, E. Helkala, M. Viitanen, B. Winblad et al., Leisuretime physical activity at midlife and the risk of dementia and Alzheimer's disease, Lancet Neurol, vol.4, pp.705-711, 2005.

Y. Y. Ruan, W. Zhai, X. M. Shi, L. Zhang, and Y. L. Hu, Safflower yellow ameliorates cognition deficits and reduces tau phosphorylation in APP/PS1 transgenic mice, Metab Brain Dis, pp.1-10, 2016.

C. C. Rudy, H. C. Hunsberger, D. S. Weitzner, and M. N. Reed, The role of the tripartite glutamatergic synapse in the pathophysiology of Alzheimer's disease, Aging Dis, vol.6, pp.131-148, 2015.

N. Rueda and J. L. Trejo, Both increases in immature dentate neuron number and decreases of immobility time in the forced swim test occurred in parallel after environmental enrichment of mice, Neuroscience, vol.147, pp.631-638, 2007.

A. Ruitenberg, A. Ott, J. C. Van-swieten, A. Hofman, and M. M. Breteler, Incidence of dementia: does gender make a difference, Neurobiol Aging, vol.22, pp.575-580, 2001.

M. Rusanen, M. Kivipelto, C. P. Quesenberry, J. Zhou, and R. A. Whitmer, Heavy smoking in midlife and long-term risk of Alzheimer Disease and vascular dementia, Arch Intern Med, vol.171, pp.333-339, 2011.

D. J. Ryan, G. K. Stebbings, and G. L. Onambele, The emergence of sedentary behaviour physiology and its effects on the cardiometabolic profile in young and older adults, Age (Dordr), vol.37, pp.1-11, 2015.

J. P. Ryan, D. F. Fine, and C. Rosano, Type 2 Diabetes and Cognitive Impairment: Contributions from Neuroimaging, vol.100, pp.130-134, 2014.

J. W. Ryder, A. V. Chibalin, and J. R. Zierath, Intracellular mechanisms underlying increases in glucose uptake in response to insulin or exercise in skeletal muscle, Acta Physiol Scand, vol.171, pp.249-257, 2001.

F. M. Sacks, G. A. Bray, V. J. Carey, S. R. Smith, D. H. Ryan et al., Comparison of weight-loss diets with different compositions of fat, protein, and carbohydrates, N Engl J Med, vol.360, pp.859-873, 2009.

J. S. Saczynski, S. Siggurdsson, P. V. Jonsson, G. Eiriksdottir, E. Olafsdottir et al., Glycemic Status and Brain Injury in Older Individuals, Diabetes Care, vol.32, pp.1608-1613, 2009.

M. Sakono and T. Zako, Amyloid oligomers: Formation and toxicity of A? oligomers, FEBS J, vol.277, pp.1348-1358, 2010.

H. Sakurai, H. Chiba, H. Miyoshi, T. Sugita, and W. Toriumi, IkB kinases phosphorylate NF-kB p65 subunit on serine 536 in the transactivation domain, J Biol Chem, vol.274, pp.30353-30356, 1999.

M. Salkovic-petrisic, A. Knezovic, S. Hoyer, and P. Riederer, What have we learned from the streptozotocin-induced animal model of sporadic Alzheimer's disease, about the therapeutic strategies in Alzheimer's research, J Neural Transm, vol.120, pp.233-252, 2013.

M. Salkovic-petrisic, J. Osmanovic-barilar, M. K. Brückner, S. Hoyer, T. Arendt et al., Cerebral amyloid angiopathy in streptozotocin rat model of sporadic Alzheimer's disease: A long-term follow up study, J Neural Transm, vol.118, pp.765-772, 2011.

A. Salminen and K. Kaarniranta, Regulation of the aging process by autophagy, Trends Mol Med, vol.15, pp.217-224, 2009.

A. Salminen, J. Ojala, T. Suuronen, K. Kaarniranta, and A. Kauppinen, Amyloid-beta oligomers set fire to inflammasomes and induce Alzheimer's pathology, J Cell Mol Med, vol.12, pp.2255-2262, 2008.

J. F. Sanchez, L. F. Sniderhan, A. L. Williamson, S. Fan, S. Chakraborty-sett et al., Glycogen synthase kinase 3beta-mediated apoptosis of primary cortical astrocytes involves inhibition of nuclear factor kappaB signaling, Mol Cell Biol, vol.23, pp.4649-4662, 2003.

F. A. Sandhu, M. Salim, and S. B. Zain, Expression of the human beta-amyloid protein of Alzheimer's disease specifically in the brains of transgenic mice, J Biol Chem, vol.266, pp.21331-21334, 1991.

S. Sasaki-hamada, H. Sacai, and J. Oka, Diabetes onset influences hippocampal synaptic plasticity in streptozotocintreated rats, Neuroscience, vol.227, pp.293-304, 2012.

T. Sato, N. Dohmae, Y. Qi, N. Kakuda, H. Misonou et al., Potential link between amyloid beta-protein 42 and C-terminal fragment gamma 49-99 of beta-amyloid precursor protein, J Biol Chem, vol.278, pp.24294-24301, 2003.

C. A. Saura, S. Y. Choi, V. Beglopoulos, S. Malkani, D. Zhang et al., Loss of presenilin function causes impairments of memory and synaptic plasticity followed by age-dependent neurodegeneration, Neuron, vol.42, pp.23-36, 2004.

R. I. Scahill, J. M. Schott, J. M. Stevens, M. N. Rossor, and N. C. Fox, Mapping the evolution of regional atrophy in Alzheimer's disease: Unbiased analysis of fluid-registered serial MRI, Proc Natl Acad Sci, vol.99, pp.4703-4707, 2002.

N. Scarmeas, Y. Stern, M. X. Tang, R. Mayeux, and J. Luchsinger, Mediterranean diet and risk for Alzheimer's disease, AnnNeurol, vol.59, pp.912-921, 2006.

S. W. Scheff, S. T. Dekosky, and D. A. Price, Quantitative assessment of cortical synaptic density in Alzheimer's disease, Neurobiol Aging, vol.11, pp.29-37, 1990.

S. W. Scheff and D. A. Price, Synapse loss in the temporal lobe in Alzheimer's disease, Ann Neurol, vol.33, pp.190-199, 1993.

S. W. Scheff, D. A. Price, F. A. Schmitt, and E. J. Mufson, Hippocampal synaptic loss in early Alzheimer's disease and mild cognitive impairment, Neurobiol Aging, vol.27, pp.1372-1384, 2006.

D. Schenk, Immunization with amyloid-beta attenuates Alzheimer-disease-like pathology in the PDAPP mouse, Nature, vol.400, pp.173-177, 1999.

E. Scherder, R. Scherder, L. Verburgh, M. Königs, M. Blom et al., Executive Functions of Sedentary Elderly May Benefit from Walking: A Systematic Review and Meta-Analysis, Am J Geriatr Psychiatry, vol.22, pp.782-791, 2014.

G. Schettini, S. Govoni, M. Racchi, and G. Rodriguez, Phosphorylation of APP-CTF-AICD domains and interaction with adaptor proteins: signal transduction and/or transcriptional role--relevance for Alzheimer pathology, J Neurochem, vol.115, pp.1299-1308, 2010.

J. A. Schneider, N. T. Aggarwal, L. Barnes, P. Boyle, and D. A. Bennett, The neuropathology of older persons with and without dementia from community versus clinic cohorts, J Alzheimers Dis, vol.18, pp.691-701, 2009.

L. S. Schneider, F. Mangialasche, N. Andreasen, H. Feldman, E. Giacobini et al., Clinical trials and late-stage drug development for Alzheimer's disease: an appraisal from 1984 to 2014, J Intern Med, vol.275, pp.251-283, 2014.

M. Schöll, O. Almkvist, K. Axelman, E. Stefanova, A. Wall et al., Glucose metabolism and PIB binding in carriers of a His163Tyr presenilin 1 mutation, Neurobiol Aging, vol.32, pp.1388-1399, 2011.

M. Schubert, D. Gautam, D. Surjo, K. Ueki, S. Baudler et al., Role for neuronal insulin resistance in neurodegenerative diseases, Proc Natl Acad Sci, vol.101, pp.3100-3105, 2004.

A. Sclafani and A. N. Gorman, Effects of age, sex, and prior body weight on the development of dietary obesity in adult rats, Physiol Behav, vol.18, pp.1021-1026, 1977.

W. B. Scoville and D. B. Bettis, Unilateral inferior temporal lobectomy with hippocampectomy for relief of incisural herniation, Acta Neurochir, vol.47, pp.149-160, 1979.

G. Segovia, A. G. Yag, and F. Mora, Environmental enrichment promotes neurogenesis and changes the extracellular concentrations of glutamate and GABA in the hippocampus of aged rats, vol.70, pp.8-14, 2006.

D. J. Selkoe, Alzheimer's Disease : Genes, proteins, and therapy, Physiol Rev, vol.81, pp.741-766, 2001.

N. Sergeant, A. Delacourte, and L. Buée, Tau protein as a differential biomarker of tauopathies, Biochim Biophys Acta -Mol Basis Dis, vol.1739, pp.179-197, 2005.

A. Serrano-pozo, M. P. Frosch, E. Masliah, and B. T. Hyman, Neuropathological Alterations in Alzheimer Disease, Cold Spring Harb Perspect Med, vol.1, pp.6189-006189, 2011.

S. E. Setti, A. M. Littlefield, S. W. Johnson, and R. A. Kohman, Diet-induced obesity attenuates endotoxin-induced cognitive deficits, Physiol Behav, vol.141, pp.1-8, 2015.

M. H. Shanik, Y. Xu, J. Skrha, R. Dankner, Y. Zick et al., Insulin resistance and hyperinsulinemia: is hyperinsulinemia the cart or the horse?, Diabetes Care, vol.31, 2008.

A. K. Sharma, S. T. Pavlova, J. Kim, J. Kim, and L. M. Mirica, The effect of Cu2+ and Zn2+ on the A?42 peptide aggregation and cellular toxicity, Metallomics, vol.5, p.1529, 2013.

S. Sharma and G. Kaur, Neuroprotective potential of dietary restriction against kainate-induced excitotoxicity in adult male Wistar rats, Brain Res Bull, vol.67, pp.482-491, 2005.

Y. Sheen and W. Sheu, Association between hypoglycemia and dementia in patients with type 2 diabetes, Diabetes Res Clin Pract, vol.116, pp.279-287, 2016.

M. A. Sherman, M. Lacroix, F. Amar, M. E. Larson, C. Forster et al., Soluble Conformers of A? and Tau Alter Selective Proteins Governing Axonal Transport, J Neurosci, vol.36, pp.9647-9658, 2016.

R. Sherrington, E. I. Rogaev, Y. Liang, E. A. Rogaeva, G. Levesque et al., Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease, Nature, vol.375, pp.754-760, 1995.

C. Shi, K. Viccaro, H. Lee, and K. Shah, Cdk5-Foxo3 axis: initially neuroprotective, eventually neurodegenerative in Alzheimer's disease models, J Cell Sci, vol.129, pp.1815-1830, 2016.

S. Shukla, A. Sharma, V. K. Pandey, S. Raisuddin, and P. Kakkar, Concurrent acetylation of FoxO1/3a and p53 due to sirtuins inhibition elicit Bim/PUMA mediated mitochondrial dysfunction and apoptosis in berberine-treated HepG2 cells, Toxicol Appl Pharmacol, vol.291, pp.70-83, 2016.

M. O. Sim, J. R. Ham, H. I. Lee, K. Seo, . Il et al., Long-term supplementation of umbelliferone and 4-methylumbelliferone alleviates high-fat diet induced hypertriglyceridemia and hyperglycemia in mice, Chem Biol Interact, vol.216, pp.9-16, 2014.

J. Simpson and J. P. Kelly, The impact of environmental enrichment in laboratory rats-Behavioural and neurochemical aspects, Behav Brain Res, vol.222, pp.246-264, 2011.

S. S. Singh, W. N. Yap, F. Arfuso, S. Kar, C. Wang et al., Targeting the PI3K/Akt signaling pathway in gastric carcinoma: A reality for personalized medicine?, World J Gastroenterol, vol.21, pp.12261-12273, 2015.

S. Sinha and I. Lieberburg, Cellular mechanisms of beta-amyloid production and secretion, Proc Natl Acad Sci, vol.96, pp.11049-11053, 1999.

E. Sipos, A. Kurunczi, Á. Kasza, J. Horváth, K. Felszeghy et al., ) ?-Amyloid pathology in the entorhinal cortex of rats induces memory deficits: Implications for Alzheimer's disease, Neuroscience, vol.147, pp.28-36, 2007.

N. Sizemore, S. Leung, and G. R. Stark, Activation of Phosphatidylinositol 3-Kinase in Response to Interleukin-1 Leads to Phosphorylation and Activation of the NF-?B p65/RelA Subunit, Mol Cell Biol, vol.19, pp.4798-4805, 1999.

S. Skovsø, Modeling type 2 diabetes in rats using high fat diet and streptozotocin, J Diabetes Investig, vol.5, pp.349-358, 2014.

J. Sleder, Y. Chen, M. D. Cully, and G. M. Reaven, Hyperinsulinemia in fructose-induced hypertriglyceridemia in the rat, Metabolism, vol.29, pp.303-305, 1980.

G. Smale, N. R. Nichols, D. R. Brady, C. E. Finch, and W. E. Horton, Evidence for Apoptotic Cell Death in Alzheimer's Disease, Exp Neurol, vol.133, pp.225-230, 1995.

D. H. Small, V. Nurcombe, G. Reed, H. Clarris, R. Moir et al., A heparin-binding domain in the amyloid protein precursor of Alzheimer's disease is involved in the regulation of neurite outgrowth, J Neurosci, vol.14, pp.2117-2127, 1994.

V. L. Smith-swintosky, L. C. Pettigrew, S. D. Craddock, A. R. Culwell, R. E. Rydel et al., Secreted forms of betaamyloid precursor protein protect against ischemic brain injury, J Neurochem, vol.63, pp.781-784, 1994.

W. So and M. Ng, Genetics of type 2 diabetes, HKMJ, vol.6, pp.69-76, 2000.

A. Soldano and B. A. Hassan, Beyond pathology: APP, brain development and Alzheimer's disease, Curr Opin Neurobiol, vol.27, pp.61-67, 2014.

C. Solé-padullés, D. Bartrés-faz, C. Junqué, P. Vendrell, L. Rami et al., Brain structure and function related to cognitive reserve variables in normal aging, mild cognitive impairment and Alzheimer's disease, Neurobiol Aging, vol.30, pp.1114-1124, 2009.

B. Solomon, R. Koppel, D. Frankel, and E. Hanan-aharon, Disaggregation of Alzheimer beta-amyloid by site-directed mAb, Proc Natl Acad Sci, vol.94, pp.4109-4112, 1997.

B. Solomon, R. Koppel, H. E. Katzav, and T. , Monoclonal antibodies inhibit in vitro fibrillar aggregation of the Alzheimer beta-amyloid peptide, Proc Natl Acad Sci, vol.93, pp.452-455, 1996.

P. Sonksen and J. Sonksen, Insulin: understanding its action in health and disease, Br J Anaesth, vol.85, pp.69-79, 2000.

I. Soto, W. A. Grabowska, K. D. Onos, L. C. Graham, H. M. Jackson et al., Meox2 haploinsufficiency increases neuronal cell loss in a mouse model of Alzheimer's disease, Neurobiol Aging, vol.42, pp.50-60, 2016.

R. A. Sperling, P. S. Aisen, L. A. Beckett, D. A. Bennett, S. Craft et al., Toward defining the preclinical stages of Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease, Alzheimers Dement, vol.7, pp.280-292, 2011.

A. A. Spindler, M. J. Renvall, J. F. Nichols, and . Rjw, Nutritional status of patients with Alzheimer's disease: a 1-year study, J Am Diet Assoc, vol.96, pp.1013-1018, 1996.

R. A. Sperling, P. S. Aisen, L. A. Beckett, D. A. Bennett, S. Craft et al., Combination of high-fat diet-fed and low-dose streptozotocin-treated rat: A model for type 2 diabetes and pharmacological screening, Pharmacol Res, vol.52, pp.313-320, 2005.

K. Srinivasan and P. Ramarao, Animal models in type 2 diabetes research: an overview, Indian J Med Res, vol.125, pp.451-472, 2007.

I. St-amour, F. Cicchetti, and F. Calon, Immunotherapies in Alzheimer's disease: Too much, too little, too late or offtarget?, Acta Neuropathol, vol.131, pp.481-504, 2016.

S. George-hyslop, P. H. Tanzi, R. E. Polinsky, R. J. Haines, J. L. Nee et al., The Genetic Defect Causing Familial Alzheimer's Disease Maps on Chromosome 21, Science, vol.12, pp.885-890, 1987.

M. J. Stampfer, Cardiovascular disease and Alzheimer's disease: Common links, J Intern Med, vol.260, pp.211-223, 2006.

M. Stanley, S. L. Macauley, and D. M. Holtzman, Changes in insulin and insulin signaling in Alzheimer's disease: cause or consequence?, J Exp Med, vol.213, pp.1375-1385, 2016.

E. J. Starks, O. Patrick, J. Grady, S. M. Hoscheidt, A. M. Racine et al., Insulin Resistance is Associated with Higher Cerebrospinal Fluid Tau Levels in Asymptomatic APOE?4 Carriers, J Alzheimers Dis, vol.46, pp.525-533, 2015.

E. Steen, B. M. Terry, E. J. Rivera, J. L. Cannon, T. R. Neely et al., Impaired insulin and insulin-like growth factor expression and signaling mechanisms in Alzheimer's disease -is this type 3 diabetes?, J Alzheimers Dis, vol.7, pp.63-80, 2005.

Y. Stern, Cognitive reserve, Neuropsychologia, vol.47, pp.2015-2028, 2009.
URL : https://hal.archives-ouvertes.fr/hal-00863749

J. Stewart, J. Mitchell, and N. Kalant, The effects of life-long food restriction on spatial memory in young and aged Fischer 344 rats measured in the eight-arm radial and the Morris water mazes, Neurobiol Aging, vol.10, pp.669-675, 1989.

C. L. Stopford, J. C. Thompson, D. Neary, A. Richardson, and J. S. Snowden, Working memory, attention, and executive function in Alzheimer's disease and frontotemporal dementia, Cortex, vol.48, pp.429-446, 2012.

L. H. Storlien, A. B. Jenkins, D. J. Chisholm, W. S. Pascoe, S. Khouri et al., Influence of dietary fat composition on development of insulin resistance in rats. Relationship to muscle triglyceride and omega-3 fatty acids in muscle phospholipid, Diabetes, vol.40, pp.280-289, 1991.

R. G. Struble, T. Ala, P. R. Patrylo, G. J. Brewer, and X. X. Yan, Is brain amyloid production a cause or a result of dementia of the Alzheimer's type?, J Alzheimer's Dis, vol.22, pp.393-399, 2010.

C. Sturchler-pierrat, D. Abramowski, M. Duke, K. H. Wiederhold, C. Mistl et al., Two amyloid precursor protein transgenic mouse models with Alzheimer disease-like pathology, Proc Natl Acad Sci U S A, vol.94, pp.13287-13292, 1997.

M. Sugano, H. Yamato, T. Hayashi, H. Ochiai, J. Kakuchi et al., High-fat diet in low-dose-streptozotocin-treated heminephrectomized rats induces all features of human type 2 diabetic nephropathy: A new rat model of diabetic nephropathy, Nutr Metab Cardiovasc Dis, vol.16, pp.477-484, 2006.

X. J. Sun, P. Rothenberg, C. R. Kahn, J. M. Backer, E. Araki et al., Structure of the insulin receptor substrate IRS-1 defines a unique signal transduction protein, Nature, vol.352, pp.73-77, 1991.

C. Sutherland, What Are the bona fide GSK3 Substrates?, Int J Alzheimers Dis, vol.2011, pp.1-23, 2011.

I. Swenne, L. A. Borg, and C. J. Crace, Persistent reduction of pancreatic beta-cell mass after a limited period of protein-energy malnutrition in the young rat, Schnell Landström A, vol.35, pp.939-945, 1992.

A. M. Szczepanik, D. Rampe, and G. E. Ringheim, Amyloid-beta peptide fragments p3 and p4 induce pro-inflammatory cytokine and chemokine production in vitro and in vivo, J Neurochem, vol.77, pp.304-317, 2001.

T. Szkudelski, The mechanism of alloxan and streptozotocin action in B cells of the rat pancreas, Physiol Res, vol.50, pp.537-546, 2001.

A. G. Tabák, M. Jokela, T. N. Akbaraly, E. J. Brunner, M. Kivimäki et al., Trajectories of glycaemia, insulin sensitivity, and insulin secretion before diagnosis of type 2 diabetes: an analysis from the Whitehall II study, Lancet, vol.373, pp.2215-2221, 2009.

A. Taguchi and M. F. White, Insulin-Like Signaling, Nutrient Homeostasis, and Life Span, Annu Rev Physiol, vol.70, pp.191-212, 2008.

E. Tamagno, M. Parola, M. Guglielmotto, G. Santoro, P. Bardini et al., Multiple signaling events in amyloid ?-induced, oxidative stress-dependent neuronal apoptosis, Free Radic Biol Med, vol.35, pp.45-58, 2003.

R. Tamayev, D. Zhou, D. 'adamio, and L. , The interactome of the amyloid beta precursor protein family members is shaped by phosphorylation of their intracellular domains, Mol Neurodegener, vol.4, pp.1-28, 2009.

Z. S. Tan, A. Beiser, R. S. Vasan, R. Au, S. Auerbach et al., Thyroid function and the risk of Alzheimer disease: The Framingham study, Arch Intern Med, vol.168, pp.1514-1520, 2008.

Z. S. Tan, A. S. Beiser, C. S. Fox, R. Au, J. J. Himali et al., Association of metabolic dysregulation with volumetric brain magnetic resonance imaging and cognitive markers of subclinical brain aging in middle-aged adults: The Framingham offspring study, Diabetes Care, vol.34, pp.1766-1770, 2011.

C. Tapia-rojas, F. Aranguiz, L. Varela-nallar, and N. C. Inestrosa, Voluntary Running Attenuates Memory Loss, Decreases Neuropathological Changes and Induces Neurogenesis in a Mouse Model of Alzheimer's Disease, Brain Pathol, vol.26, pp.62-74, 2016.

C. J. Taylor, D. R. Ireland, I. Ballagh, K. Bourne, N. M. Marechal et al., Endogenous secreted amyloid precursor protein-alpha regulates hippocampal NMDA receptor function, longterm potentiation and spatial memory, Neurobiol Dis, vol.31, pp.250-260, 2008.

S. I. Taylor, D. Accili, and Y. Imai, Insulin resistance or insulin deficiency. Which is the primary cause of NIDDM?, Diabetes, vol.43, pp.735-740, 1994.

N. M. Templeman, S. Skovsø, M. M. Page, G. E. Lim, and J. D. Johnson, A causal role for hyperinsulinemia in obesity, J Endocrinol, vol.3, pp.16-0449, 2017.

V. Tentolouris-piperas, N. S. Ryan, D. L. Thomas, and K. M. Kinnunen, Brain imaging evidence of early involvement of subcortical regions in familial and sporadic Alzheimer's disease, Brain Res, vol.1655, pp.23-32, 2016.

J. P. Terranova, J. P. Kan, J. J. Storme, P. Perreaut, L. Fur et al., Administration of amyloid ?-peptides in the rat medial septum causes memory deficits: Reversal by SR 57746A, a non-peptide neurotrophic compound, Neurosci Lett, vol.213, pp.79-82, 1996.

R. D. Terry, Neuropathological changes in Alzheimer disease, Prog Brain Res, vol.101, pp.383-390, 1994.

R. D. Terry, E. Masliah, D. P. Salmon, N. Butters, R. Deteresa et al., Physical Basis of Cognitive Alterations in Alzheimer' s Disease : Synapse h s s Is the Major Correlate of Cognitive Impairment, pp.572-580, 1991.

D. Terwel, D. Muyllaert, I. Dewachter, P. Borghgraef, S. Croes et al., Amyloid Activates GSK-3? to Aggravate Neuronal Tauopathy in Bigenic Mice, Am J Pathol, vol.172, pp.786-798, 2008.

D. R. Thal, U. Rüb, M. Orantes, and H. Braak, Phases of A beta-deposition in the human brain and its relevance for the development of AD, Neurology, vol.58, pp.1791-1800, 2002.

D. R. Thal, I. Sassin, C. Schultz, C. Haass, E. Braak et al., Fleecy amyloid deposits in the internal layers of the human entorhinal cortex are comprised of N-terminal truncated fragments of Abeta, J Neuropathol Exp Neurol, vol.58, pp.210-216, 1999.

J. Thomas, M. L. Garg, and D. W. Smith, Altered expression of histone and synaptic plasticity associated genes in the hippocampus of streptozotocin-induced diabetic mice, Metab Brain Dis, vol.28, pp.613-618, 2013.

P. M. Thompson, K. M. Hayashi, R. A. Dutton, M. C. Chiang, A. D. Leow et al., Tracking Alzheimer's Disease, Ann N Y Acad Sci, pp.183-214, 2007.

E. Thornton, R. Vink, and P. C. Blumbergs, Van Den Heuvel C (2006) Soluble amyloid precursor protein ? reduces neuronal injury and improves functional outcome following diffuse traumatic brain injury in rats, Brain Res, vol.1094, pp.38-46

J. S. Tilstra, C. L. Clauson, L. J. Niedernhofer, and P. D. Robbins, NF-?B in Aging and Disease, Aging Dis, vol.2, pp.449-465, 2011.

M. K. Tiwari and K. P. Kepp, Modeling the Aggregation Propensity and Toxicity of Amyloid-? Variants Acquaah-Mensah G, J Alzheimer's Dis, vol.47, pp.215-229, 2015.

L. Tornatore, A. K. Thotakura, J. Bennett, M. Moretti, and G. Franzoso, The nuclear factor kappa B signaling pathway: Integrating metabolism with inflammation, Trends Cell Biol, vol.22, pp.557-566, 2012.

M. Townsend, T. Mehta, and D. J. Selkoe, Soluble Abeta Inhibits Specific Signal Transduction Cascades Common to the Insulin Receptor Pathway, J Biol Chem, vol.282, pp.33305-33312, 2007.

M. Townsend, G. M. Shankar, T. Mehta, D. M. Walsh, and D. J. Selkoe, Effects of secreted oligomers of amyloid betaprotein on hippocampal synaptic plasticity: a potent role for trimers, J Physiol, vol.572, pp.477-492, 2006.

J. L. Trejo, E. Carro, and I. Torres-aleman, Circulating insulin-like growth factor I mediates exercise-induced increases in the number of new neurons in the adult hippocampus, J Neurosci, vol.21, pp.1628-1634, 2001.

F. Trinchese, S. Liu, F. Battaglia, S. Walter, P. M. Mathews et al., Progressive age-related development of Alzheimer-like pathology in APP/PS1 mice, Ann Neurol, vol.55, pp.801-814, 2004.

F. Trinchese, S. Liu, and H. Zhang, Inhibition of calpains improves memory and synaptic transmission in a mouse model of Alzheimer disease, J Clin Invest, vol.118, pp.2796-2807, 2008.

. Tripathy, RSSDI Textbook of Diabetes Mellitus, 2012.

J. Q. Trojanowski and V. Lee, Fatal Attractions " of Proteins Underlying Alzheimer ' s Disease and Other, Ann New York Acad Sci, vol.924, pp.62-67, 2000.

D. Tromp, A. Dufour, S. Lithfous, T. Pebayle, and O. Despres, Episodic memory in normal aging and Alzheimer disease: Insights from imaging and behavioral studies, Ageing Res Rev, vol.24, pp.232-262, 2015.

J. C. Troncoso, L. J. Martin, D. Forno, G. Kawas, and C. H. , Neuropathology in controls and demented subjects from the Baltimore Longitudinal Study of Aging, Neurobiol Aging, vol.17, pp.365-371, 1996.

J. Tsai, J. Grutzendler, K. Duff, and W. Gan, Fibrillar amyloid deposition leads to local synaptic abnormalities and breakage of neuronal branches, Nat Neurosci, vol.7, pp.1181-1183, 2004.

Z. Tucsek, P. Toth, D. Sosnowska, T. Gautam, M. Mitschelen et al., Obesity in aging exacerbates blood-brain barrier disruption, neuroinflammation, and oxidative stress in the mouse hippocampus: effects on expression of genes involved in beta-amyloid generation and Alzheimer's disease, J Gerontol A Biol Sci Med Sci, vol.69, pp.1212-1226, 2014.

S. L. Tyas, D. A. Snowdon, M. F. Desrosiers, K. P. Riley, and W. R. Markesbery, Healthy ageing in the Nun Study: definition and neuropathologic correlates, Age Ageing, vol.36, pp.650-655, 2007.

M. Tytus, G. Pd, and S. Thuret, Effects of diet on brain plasticity in animal and human studies: Mind the gap, Neural Plast, vol.2014, pp.1-32, 2014.

G. Tzivion, M. Dobson, and G. Ramakrishnan, FoxO transcription factors; Regulation by AKT and 14-3-3 proteins, Biochim Biophys Acta -Mol Cell Res, vol.1813, pp.1938-1945, 2011.

G. Tzivion and N. Hay, PI3K-AKT-FoxO axis in cancer and aging, Biochim Biophys Acta -Mol Cell Res, vol.1813, 1925.

A. Vaag, C. Brøns, L. Gillberg, N. S. Hansen, L. Hjort et al., Genetic, nongenetic and epigenetic risk determinants in developmental programming of type 2 diabetes, Acta Obstet Gynecol Scand, vol.93, pp.1099-1108, 2014.

J. Valero, J. España, A. Parra-damas, E. Martín, J. Rodríguez-Álvarez et al., Short-term environmental enrichment rescues adult neurogenesis and memory deficits in APP(Sw,Ind) transgenic mice, PLoS One, vol.6, p.16832, 2011.

I. Valladolid-acebes, A. Fole, M. Martín, L. Morales, V. Cano et al., Spatial memory impairment and changes in hippocampal morphology are triggered by high-fat diets in adolescent mice. Is there a role of leptin?, Neurobiol Learn Mem, vol.106, pp.18-25, 2013.

C. Van-cauwenberghe, C. Vandendriessche, C. Libert, and R. E. Vandenbroucke, Caloric restriction: beneficial effects on brain aging and Alzheimer's disease, Mamm Genome, vol.27, pp.300-319, 2016.

M. Van-de-ree, M. Huisman, H. M. Princen, A. Meinders, and C. Kluft, Strong decrease of high sensitivity C-reactive protein with high-dose atorvastatin in patients with type 2 diabetes mellitus, Atherosclerosis, vol.166, pp.129-135, 2003.

L. P. Van-der-heide, G. Ramakers, and M. P. Smidt, Insulin signaling in the central nervous system: Learning to survive, Prog Neurobiol, vol.79, pp.205-221, 2006.

W. E. Van-nostrand, J. S. Farrow, S. L. Wagner, R. Bhasin, D. Goldgaber et al., The predominant form of the amyloid beta-protein precursor in human brain is protease nexin 2, Proc Natl Acad Sci, vol.88, pp.10302-10306, 1991.

H. Van-praag, Exercise enhances learning and hippocampal neurogenesis in aged mice, J Neurosci, vol.25, pp.8680-8685, 2005.

H. Van-praag, Exercise and the brain: something to chew on, Trends Neurosci, vol.32, pp.283-290, 2009.

H. Van-praag, B. R. Christie, T. J. Sejnowski, and F. H. Gage, Running enhances neurogenesis, learning, and longterm potentiation in mice, Proc Natl Acad Sci, vol.96, pp.13427-13431, 1999.

H. Van-praag, G. Kempermann, and F. H. Gage, Running increases cell proliferation and neurogenesis in the adult mouse dentate gyrus, Nat Neurosci, vol.2, pp.266-270, 1999.

H. Van-praag, G. Kempermann, and F. H. Gage, Neural consequences of environmental enrichment, Nat Rev Neurosci, vol.1, pp.191-198, 2000.

C. H. Vanderwolf, Effect of combined medial thalamic and septal lesions on active-avoidance behavior, J Comp Physiol Psychol, vol.58, pp.31-37, 1964.

S. D. Vann and M. M. Albasser, Hippocampus and neocortex: recognition and spatial memory, Curr Opin Neurobiol, vol.21, pp.440-445, 2011.

R. Vassar, Beta-secretase cleavage of Alzheimer's amyloid precursor protein by the transmembrane aspartic protease BACE, Science, vol.286, pp.735-741, 1999.

R. Vassar, D. M. Kovacs, R. Yan, and P. C. Wong, The beta-secretase enzyme BACE in health and Alzheimer's disease: regulation, cell biology, function, and therapeutic potential, J Neurosci, vol.29, pp.12787-12794, 2009.

S. Vaynman, Z. Ying, and F. Gomez-pinilla, Hippocampal BDNF mediates the efficacy of exercise on synaptic plasticity and cognition, Eur J Neurosci, vol.20, pp.2580-2590, 2004.

J. Ventura-sobrevilla, V. D. Boone-villa, C. N. Aguilar, R. Román-ramos, E. Vega-avila et al., Effect of varying dose and administration of streptozotocin on blood sugar in male CD1 mice, Proc West Pharmacol Soc, vol.54, pp.5-9, 2011.

S. Vepsäläinen, M. Hiltunen, S. Helisalmi, J. Wang, T. Van-groen et al., Increased expression of A? degrading enzyme IDE in the cortex of transgenic mice with Alzheimer's disease-like neuropathology, Neurosci Lett, vol.438, pp.216-220, 2008.

G. Verdile, . Kkn, . Cvf, . Ms, . Sm et al., Inflammation and Oxidative Stress: The Molecular Connectivity between Insulin Resistance, Obesity, and Alzheimer's Disease, Mediators Inflamm, 2015.

L. Verret, A. Krezymon, H. Halley, S. Trouche, M. Zerwas et al., Transient enriched housing before amyloidosis onset sustains cognitive improvement in Tg2576 mice, Neurobiol Aging, vol.34, pp.211-225, 2013.
URL : https://hal.archives-ouvertes.fr/hal-02360490

B. Vessby, M. Uusitupa, K. Hermansen, G. Riccardi, A. A. Rivellese et al., Substituting dietary saturated for monounsaturated fat impairs insulin sensitivity in healthy men and women: The KANWU Study, Diabetologia, vol.44, pp.312-319, 2001.

V. L. Villemagne, K. E. Pike, G. Chételat, K. A. Ellis, R. S. Mulligan et al., Longitudinal assessment of A? and cognition in aging and Alzheimer disease, Ann Neurol, vol.69, pp.181-192, 2011.

M. Virally, J. Blicklé, J. Girard, S. Halimi, D. Simon et al., Type 2 diabetes mellitus: epidemiology, pathophysiology, unmet needs and therapeutical perspectives, Diabetes Metab, vol.33, pp.231-244, 2007.

D. Virgintino, D. Robertson, P. Monaghan, M. Errede, M. Bertossi et al., Glucose transporter GLUT1 in human brain microvessels revealed by ultrastructural immunocytochemistry, J Submicrosc Cytol Pathol, vol.29, pp.365-370, 1997.

C. Vivar, M. C. Potter, and H. Van-praag, All about running: Synaptic plasticity, Growth factors and dult hippocampal neurogenesis, Current topics in behavioral neurosciences, pp.189-210, 2012.

V. Von-diemen, E. N. Trindade, and M. Trindade, Experimental model to induce obesity in rats, Acta Cir Bras, vol.21, pp.425-429, 2006.

R. C. Von-rotz, B. M. Kohli, J. Bosset, M. Meier, T. Suzuki et al., The APP intracellular domain forms nuclear multiprotein complexes and regulates the transcription of its own precursor, J Cell Sci, vol.117, pp.4435-4448, 2004.

S. Vos, B. A. Gordon, Y. Su, P. J. Visser, D. M. Holtzman et al., NIA-AA staging of preclinical Alzheimer disease: Discordance and concordance of CSF and imaging biomarkers, Neurobiol Aging, vol.44, pp.1-8, 2016.

J. M. Walker, S. Dixit, A. C. Saulsberry, J. M. May, and F. E. Harrison, Reversal of high fat diet-induced obesity improves glucose tolerance, inflammatory response, ?-amyloid accumulation and cognitive decline in the APP/PSEN1 mouse model of Alzheimer's disease, Neurobiol Dis, vol.100, pp.87-98, 2017.

J. M. Walker and F. E. Harrison, Shared neuropathological characteristics of obesity, type 2 diabetes and Alzheimer's disease: Impacts on cognitive decline, Nutrients, vol.7, 2015.

D. M. Walsh, I. Klyubin, J. Fadeeva, W. K. Cullen, R. Anwyl et al., Naturally secreted oligomers of amyloid beta protein potently inhibit hippocampal long-term potentiation in vivo, Nature, vol.416, pp.535-539, 2002.

H. Wang and G. Reiser, Thrombin Signaling in the Brain: The role of protease-activated receptors, Biol Chem, vol.384, pp.193-202, 2003.

J. Wang, L. Ho, W. Qin, A. B. Rocher, I. Seror et al., Caloric restriction attenuates beta-amyloid neuropathology in a mouse model of Alzheimer's disease, FASEB J, vol.19, pp.659-661, 2005.

Q. Wang, M. J. Rowan, and R. Anwyl, ?-amyloid mediated inhibition of NMDA receptor-dependent long-term otentiation induction involves activation of microglia and stimulation of inducible nitric oxide synthase and superoxide, J Neurosci, vol.24, pp.6049-6056, 2004.

Z. Wang, T. Lan, J. Liu, and J. Yu, The essential role of soluble A? oligomers in Alzheimer's Disease, Mol Neurobiol, pp.1905-1924, 2016.

Z. Wang, B. Wang, L. Yang, Q. Guo, N. Aithmitti et al., Presynaptic and postsynaptic interaction of the amyloid precursor protein promotes peripheral and central synaptogenesis, J Neurosci, vol.29, pp.10788-10801, 2009.

N. Watamura, J. Toba, A. Yoshii, M. Nikkuni, and T. Ohshima, Colocalization of phosphorylated forms of WAVE1, CRMP2, and tau in Alzheimer's disease model mice: Involvement of Cdk5 phosphorylation and the effect of ATRA treatment, J Neurosci Res, vol.94, pp.15-26, 2016.

A. E. Webb and A. Brunet, FOXO transcription factors: key regulators of cellular quality control, Trends Biochem Sci, vol.39, pp.159-169, 2015.

S. J. Webster, A. D. Bachstetter, P. T. Nelson, and L. J. Schmitt-f-a,-van-eldik, Using mice to model Alzheimer's dementia: an overview of the clinical disease and the preclinical behavioral changes in 10 mouse models, Front Genet, vol.5, p.88, 2014.

W. Wei, X. Wang, and J. W. Kusiak, Signaling events in amyloid beta-peptide-induced neuronal death and insulin-like growth factor I protection, J Biol Chem, vol.277, pp.17649-17656, 2002.

M. W. Weiner, Update of the Alzheimer's Disease Neuroimaging Initiative: A review of papers published since its inception, Alzheimers Dement, vol.11, pp.1-120, 2015.

H. Werner and D. Leroith, Insulin and insulin-like growth factor receptors in the brain: Physiological and pathological aspects, Eur Neuropsychopharmacol, vol.24, pp.1947-1953, 2014.

M. A. Westerman, D. Cooper-blacketer, A. Mariash, L. Kotilinek, T. Kawarabayashi et al., The relationship between Abeta and memory in the Tg2576 mouse model of Alzheimer's disease, J Neurosci, vol.22, pp.1858-1867, 2002.

R. A. Whitmer, E. P. Gunderson, C. P. Quesenberry, J. Zhou, and K. Yaffe, Body mass index in midlife and risk of Alzheimer disease and vascular dementia, Curr Alzheimer Res, vol.4, pp.103-109, 2007.

D. C. Willcox, G. Scapagnini, and B. J. Willcox, Healthy aging diets other than the Mediterranean: A focus on the Okinawan diet, Mech Ageing Dev, vol.136, pp.148-162, 2014.

A. A. Willette, S. C. Johnson, A. C. Birdsill, M. A. Sager, B. Christian et al., Insulin resistance predicts brain amyloid deposition in late middle-aged adults, Alzheimers Dement, vol.11, pp.504-510, 2015.

J. A. Willis, R. S. Scott, L. J. Brown, L. Forbes, R. S. Schmidli et al., Islet cell antibodies and antibodies against glutamic acid decarboxylase in newly diagnosed adult-onset diabetes mellitus, Diabetes Res Clin Pract, vol.33, pp.89-97, 1996.

E. A. Winkler, GLUT1 reductions exacerbate Alzheimer's disease vasculo-neuronal dysfunction and degeneration, Nat Neurosci, vol.18, pp.521-530, 2015.

M. S. Winzell and B. Ahren, The high-fat diet-fed mouse: a model for studying mechanisms and treatment of impaired glucose tolerance and Type 2 Diabetes, Diabetes, vol.237, pp.215-219, 2004.

D. O. Wirak, R. Bayney, C. A. Kundel, A. Lee, G. A. Scangos et al., Regulatory region of human amyloid precursor protein (APP) gene promotes neuron-specific gene expression in the CNS of transgenic mice, EMBO J, vol.10, pp.289-296, 1991.

E. Wirawan, T. Berghe, . Vanden, S. Lippens, P. Agostinis et al., Autophagy: for better or for worse, Cell Res, vol.22, pp.43-61, 2012.

T. Wisniewski and E. M. Sigurdsson, Murine models of Alzheimer's disease and their use in developing immunotherapies, Biochim Biophys Acta, vol.1802, pp.847-859, 2010.

A. V. Witte,

M. Fobker,

R. Gellner, S. Knecht, and . Fa, Caloric restriction improves memory in elderly humans, Proc Natl Acad Sci, vol.106, pp.1255-1260, 2009.

K. A. Wollen, Alzheimer's Disease: The Pros and Cons of Pharmaceutical, Nutritional, Botanical, and Stimulatory Therapies, with a Discussion of Treatment Strategies from the Perspective of Patients and Practitioners, Altern Med Rev, vol.15, issue.3, pp.223-244, 2010.

H. Wong, T. Veremeyko, N. Patel, C. A. Lemere, D. M. Walsh et al., Derepression of FOXO3a death axis by microRNA-132 and -212 causes neuronal apoptosis in Alzheimer's disease, Hum Mol Genet, vol.22, pp.3077-3092, 2013.

J. Woo, K. Shin, S. Park, K. Jang, and S. Kang, Effects of exercise and diet change on cognition function and synaptic plasticity in high fat diet induced obese rats, Lipids Health Dis, vol.12, p.144, 2013.

S. C. Woods, R. J. Seeley, D. Rushing-p-a,-d'alessio, and P. Tso, A controlled high-fat diet induces an obese syndrome in rats, J Nutr, vol.133, pp.1081-1087, 2003.

Y. L. Woods, G. Rena, N. Morrice, A. Barthel, W. Becker et al., The kinase DYRK1A phosphorylates the transcription factor FKHR at Ser329 in vitro, a novel in vivo phosphorylation site, Biochem J, vol.355, pp.597-607, 2001.

, Global status report on Noncommunicable Diseases, pp.1-302, 2014.

, Diabetes Mellitus.WHO 1-113, 1985.

, Obesity: preventing and managing the global epidemic, World Health Organ Tech Rep Ser, vol.894, pp.1-253, 2000.

, Global Status Report On Noncommunicable Diseases, 2014.

C. Wu, Y. Chang, Y. L. Chen, H. Jen, C. J. Wu et al., Exercise enhances the proliferation of neural stem cells and neurite growth and survival of neuronal progenitor cells in dentate gyrus of middle-aged mice, J Appl Physiol, vol.105, pp.1585-1594, 2008.

P. Wu, Q. Shen, S. Dong, Z. Xu, J. Z. Tsien et al., Calorie restriction ameliorates neurodegenerative phenotypes in forebrain-specific presenilin-1 and presenilin-2 double knockout mice, Neurobiol Aging, vol.29, pp.1502-1511, 2008.

S. Wullschleger, R. Loewith, and M. N. Hall, TOR signaling in growth and metabolism, Cell, vol.124, pp.471-484, 2006.

Q. Xiang, J. Zhang, C. Y. Li, Y. Wang, M. J. Zeng et al., Insulin resistance-induced hyperglycemia decreased the activation of Akt/CREB in hippocampus neurons: Molecular evidence for mechanism of diabetes-induced cognitive dysfunction, Neuropeptides, vol.54, pp.9-15, 2015.

H. Xie, J. M. Litersky, J. A. Hartigan, R. S. Jope, and G. Johnson, The interrelationship between selective tau phosphorylation and microtubule association, Brain Res, vol.798, pp.173-183, 1998.

Z. Xie and D. J. Klionsky, Autophagosome formation: core machinery and adaptations, Nat Cell Biol, vol.9, pp.1102-1109, 2007.

F. Yang, X. Chu, M. Yin, X. Liu, H. Yuan et al., MTOR and autophagy in normal brain aging and caloric restriction ameliorating age-related cognition deficits, Behav Brain Res, vol.264, pp.82-90, 2014.

L. Yang, P. Li, S. Fu, E. S. Calay, and G. S. Hotamisligil, Defective hepatic autophagy in obesity promotes ER stress and causes insulin resistance, Cell Metab, vol.11, pp.467-478, 2010.

B. A. Yankner, L. R. Dawes, S. Fisher, L. Villa-komaroff, M. L. Oster-granite et al., Neurotoxicity of a fragment of the amyloid precursor associated with Alzheimer's disease, Science, vol.245, pp.417-420, 1989.

H. Yao, X. Han, and X. Han, The Cardioprotection of the Insulin-Mediated PI3K/Akt/mTOR Signaling Pathway, Am J Cardiovasc Drugs, vol.14, pp.433-442, 2014.

J. Ye and J. N. Keller, Regulation of energy metabolism by inflammation: A feedback response in obesity and calorie restriction, Aging (Albany NY), vol.2, pp.361-368, 2010.

R. Yin, K. Yin, Z. Q. Guo, Z. Q. Zhang, L. P. Chen et al., Protective effects of colivelin against Alzheimer's disease in a PDAPP mouse model, Cell Physiol Biochem, vol.38, pp.1138-1146, 2016.

J. Yip, X. Geng, J. Shen, and Y. Ding, Cerebral Gluconeogenesis and Diseases. Front Pharmacol, vol.7, p.521, 2017.

J. Yong, K. B. Shin, O. Woo, J. Heon, and S. , Exercise and dietary change ameliorate high fat diet induced obesity and insulin resistance via mTOR signaling pathway, vol.20, pp.28-33, 2016.

Y. Yoshiike, T. Kimura, S. Yamashita, H. Furudate, T. Mizoroki et al., GABA(A) receptormediated acceleration of aging-associated memory decline in APP/PS1 mice and its pharmacological treatment by picrotoxin, PLoS One, vol.3, p.3029, 2008.

C. Yu, M. Rahmani, Y. Dai, D. Conrad, G. Krystal et al., The lethal effects of pharmacological cyclindependent kinase inhibitors in human leukemia cells proceed through a phosphatidylinositol 3-kinase/Aktdependent process, Cancer Res, vol.63, pp.1822-1833, 2003.

H. Yu, C. A. Saura, S. Y. Choi, L. D. Sun, X. Yang et al., APP processing and synaptic plasticity in presenilin-1 conditional knockout mice, Neuron, vol.31, pp.713-726, 2001.

J. Yu, J. T. Guo, H. Zhu, and M. S. Kindy, Amyloid formation in the rat: adenoviral expression of mouse serum amyloid A proteins, Amyloid, vol.7, pp.32-40, 2000.

C. M. Yuede, S. D. Zimmerman, H. Dong, M. J. Kling, A. W. Bero et al., Effects of voluntary and forced exercise on plaque deposition, hippocampal volume, and behavior in the Tg2576 mouse model of Alzheimer's disease, Neurobiol Dis, vol.35, pp.426-432, 2009.

W. Zago, M. Buttini, T. A. Comery, C. Nishioka, S. J. Gardai et al., Neutralization of soluble, synaptotoxic amyloid beta species by antibodies is epitope specific, J Neurosci, vol.32, pp.2696-2702, 2012.

E. Zandi, D. M. Rothwarf, M. Delhase, M. Hayakawa, and M. Karin, The IkB Kinase Complex (IKK) Contains Two Kinase Subunits, IKK?1and IKK?2, necessary for IkB phosphorylation and NFkB activation, Cell, vol.91, pp.243-252, 1997.

I. Zavaroni, S. Sander, S. Scott, and G. M. Reaven, Effect of fructose feeding on insulin secretion and insulin action in the rat, Metabolism, vol.29, pp.970-973, 1980.

H. Zhang, Q. Ma, Y. Zhang, and H. Xu, Proteolytic processing of Alzheimer's ?-amyloid precursor protein, J Neurochem, vol.120, pp.9-21, 2012.

M. Zhang, X. Lv, J. Li, Z. Xu, and L. Chen, The characterization of high-fat diet and multiple low-dose streptozotocin induced type 2 diabetes rat model, Exp Diabetes Res, p.704045, 2008.

S. Zhang, N. Smailagic, C. Hyde, A. H. Noel-storr, Y. Takwoingi et al., )C-PIB-PET for the early diagnosis of Alzheimer's disease dementia and other dementias in people with mild cognitive impairment (MCI), 2014.

, Cochrane Database of Systematic Reviews Cochrane Database Syst Rev, vol.7, pp.1-59

X. Zhang, S. Gao, J. Niu, P. Li, J. Deng et al., Cannabinoid 2 Receptor Agonist Improves Systemic Sensitivity to Insulin in High-Fat Diet/Streptozotocin-Induced Diabetic Mice, Cell Physiol Biochem, vol.40, pp.1175-1185, 2016.

X. Zhang, G. Zhang, H. Zhang, M. Karin, H. Bai et al., Hypothalamic IKK?/NF-kB and ER Stress Link Overnutrition to Energy Imbalance and Obesity, Cell, vol.135, pp.61-73, 2008.

Y. Zhang, R. Wang, Q. Liu, H. Zhang, F. Liao et al., Presenilin/gamma-secretase-dependent processing of betaamyloid precursor protein regulates EGF receptor expression, Proc Natl Acad Sci, vol.104, pp.10613-10618, 2007.

C. Zhao, Distinct Morphological Stages of Dentate Granule Neuron Maturation in the Adult Mouse Hippocampus, J Neurosci, vol.26, pp.3-11, 2006.

W. Zhao, D. Felice, F. G. Fernandez, S. Chen, H. Lambert et al., Amyloid beta oligomers induce impairment of neuronal insulin receptors, FASEB J, vol.22, pp.246-260, 2008.

Z. C. Zhao, F. Li, and K. Maiese, Oxidative stress in the brain: Novel cellular targets that govern survival during neurodegenerative disease, Prog Neurobiol, vol.75, pp.207-246, 2005.

L. Zhao, B. Teter, and T. Morihara, Insulin-Degrading Enzyme as a Downstream Target of Insulin Receptor Signaling Cascade: Implications for Alzheimer's Disease Intervention, J Neurosci, vol.24, pp.11120-11126, 2004.

Q. Zheng-fischhöfer, J. Biernat, E. M. Mandelkow, S. Illenberger, R. Godemann et al., Sequential phosphorylation of Tau by glycogen synthase kinase-3beta and protein kinase A at Thr212 and Ser214 generates the Alzheimer-specific epitope of antibody AT100 and requires a paired-helical-filament-like conformation, Eur J Biochem, vol.252, pp.542-552, 1998.

H. Zhou, X. M. Li, J. Meinkoth, and R. N. Pittman, Akt regulates cell survival and apoptosis at a postmitochondrial level, J Cell Biol, vol.151, pp.483-494, 2000.

F. Aguiree, A. Brown, N. Cho, and G. Dahlquist, ) IDF Diabetes Atlas. International Diabetes Federation, vol.03, pp.1-155, 2013.

, Classification and Diagnosis of Diabetes, Diabetes Care, vol.38, pp.8-16, 2015.

Z. Arvanitakis, R. S. Wilson, J. L. Bienias, D. Evans, and D. Bennett, Diabetes mellitus and risk of Alzheimer disease and decline in cognitive function, Arch Neurol, vol.61, pp.661-666, 2004.

A. Brunetti, E. Chiefari, and D. Foti, Recent advances in the molecular genetics of type 2 diabetes mellitus, World J Diabetes, vol.5, pp.128-140, 2014.

A. Caccamo, M. A. Maldonado, S. Majumder, D. X. Medina, W. Holbein et al., Naturally secreted amyloid-b increases mammalian target of rapamycin (mTOR) activity via a PRAS40-mediated mechanism, J Biol Chem, vol.286, pp.8924-8932, 2011.